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ABSTRACT 
The transmission of mechanical forces controls a multitude of cellular processes such as 
migration, the formation of new organs, muscle contraction, and resistance to the continuous 
stress that blood flow exerts on the blood vessel wall. 
These forces are sensed and replayed at the sites of cellular adhesion to the basal membrane 
as well as cell-cell junctions, where protein complexes connect to the cellular cytoskeleton to 
relay force into the cell. During vascular development, endothelial cells (ECs) continuously 
sense and respond to mechanical cues from the microenvironment to form a functional and 
hierarchical vessel network. Uncovering the underlying mechanisms, by which the 
mechanical tension is generated, sensed, and relayed into the cell is important in advancing 
our understanding of the pathogenesis of vascular disease. In this thesis, evidence is presented 
for a role of the Angiomotin (Amot) scaffold protein family as essential mediators in the 
vascular endothelium.  
As stated in Paper I, deletion of Amot in the endothelium inhibits the expansion of the 
physiological and pathological vascular network. Furthermore, we provide evidence that 
Amot is a novel component of the integrin adhesome important for linking fibronectin (Fn) in 
the extra-cellular matrix (ECM) to the intercellular actin filaments. Fn is a major component 
in the ECM, which is sensitive to mechanical forces resulting in extensive molecular 
elongation. In Paper II, the force-sensitive “integrin switch” of Fn-binding sites is 
experimentally confirmed, and an engineered scFv named H5 is developed, which 
specifically binds to that force-induced conformational change of Fn. We provide further 
experimental evidence both in vitro and ex vivo for the H5 ability to detect and target the 
early molecular signatures of cell contractile forces in vivo.  
Transmission of mechanical force occurs not only via cell-matrix adhesions but also cell-cell 
junctions. As described in Paper III, AmotL1 forms a complex with N-cadherin presented on 
both ECs and pericytes. Exploiting endothelial-specific knockout mice, we demonstrate that 
AmotL1 is essential for normal establishment of vascular networks in the post-natal mouse 
retina and in a transgenic breast cancer model. In Paper IV, we indicate that AmotL2 
connects junctional VE-cadherin and radial actin filaments to the LINC complex in the 
nuclear membrane. Deletion of AmotL2 impairs the formation of radial actin filaments and 
the flow-induced alignment of aortic ECs and affects nuclear shape and positioning. 
Moreover, the absence of AmotL2 in ECs provokes a pro-inflammatory response and 
abdominal aortic aneurysms in the aortae of adult mice that are consuming a normal diet.  
Overall, these findings provide a conceptual framework regarding force mechanotransduction 
via cell-matrix adhesions and cell-cell junctions that are associated with vascular physiology 
and relevant diseases.  
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1 INTRODUCTION 
Force is a general concept that describes the push or pull on an object resulting from its 
interaction with another object. When the interaction ceases, the force is no longer applied. 
As a vector, force has both magnitude and direction, and it can thus be measured and 
quantified along a certain direction in a specific time point. Force is classified into two broad 
categories: action-at-a-distance force and contact force. As its name suggests, contact force, 
unlike action-at-a-distance forces, such as gravitational and electrical force, is exerted when 
two objects come into a direct physical contact. The force discussed in this thesis is mainly 
tension (tensional force), one of the most common contact forces.  
As illustrated in Figure 1, the tension force is the force transmitted through a rope or similar 
string when it is pulled taught by force acting from opposite ends. The length of the rope 
determines the significant distance over which the force can be transferred.   
            
 
Figure 1. Ready to pull. The tension force is generated by two athletes and transmitted axially 
through the rope. The statue “Kamp” (Struggle) was exhibited at the National Sports Museum in 




In the context of the field of biology, mechanical force influences the morphology, mobility 
and functionality of virtually every cell, tissue and organ in our bodies. Once the mechanical 
properties of tissues are altered, certain human diseases may occur. In recent decades, an 
increasing number of studies have aimed to characterize the process of force sensing, 
transmission and transduction into bio-signals, to reveal molecules and mechanisms of 
coordinating cell internal structure and external mechanical inputs and so on. The subject of 
mechanobiology therefore emerged at the interface of physics and biology, and it 
encompasses novel biotechnologies and experimental approaches, as well as cell and 
development biology.  
As early as 1943, Holtfreter, an embryologist of Entwicklungsmechnik (developmental 
mechanics) movement, had articulated embryo morphogenesis as a physical, mechanical 
issue: that is, cells generate force to remodel the embryo (Holtfreter, 1943). Shortly 
thereafter, he published two hypotheses explaining the movement of embryonic tissues. One 
of these is the concept of mechanically integrated cell migrating behavior (Holtfreter, 1944; 
Keller, 2012). In the 1980s, Donald Ingber and colleagues reported that the extracellular 
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matrix (ECM) surrounding the cells has an impact on cell function and DNA synthesis 
(Sauer, 1987). Due to limitations in technique, the mechanisms were not well explained. This 
holistic mechanical view was overwhelmed by reductionist studies of molecular biology at 
the genetic level. However with the rapid development of approaches with which to 
manipulate and measure force, mechanical forces have gradually returned to the spotlight of 
modern research in various areas, such as embryogenesis, tissue development, stem cells and 
cancer progression (Piccolo, 2013; Schwartz, 2010a; Butcher, Alliston and Weaver, 2009; 
Fredberg et al., 2009; Wozniak and Chen, 2009; Bissell and Hines, 2011). It appears that the 
biological effect of forces are not limited to physical activity from heart pumping to single 
cell migration, but can also regulate a wide variety of processes, such as cell proliferation and 
tissue homeostasis. 
To explore how mechanical forces affect the cells, we need to consider that most cells in our 
bodies are not solitaries, but in direct physical contact with the environment, including the 
ECM, or other neighboring cells, or, often both. It is a starting point to recognize and 
understand the cellular structural basis on which forces are generated, transmitted and 
transduced into biochemical signals. 
A simplified schematic in Figure 2 presents three key contributors to cellular mechano-
sensing and -adaption: integrin mediated focal adhesion (FA) between the cell and ECM, 
tissue-specific cadherin based adhesion junction (AJ) and internal contractile machinery 
formed by actin-myosin network. Both the cell surface complexes, that is, FAs and AJs, link 
associated receptors to actin cytoskeleton (Sastry and Burridge, 2000; Gumbiner, 2005). Of 
course, the constructional and functional situation in reality is much more sophisticated than 
the simplified diagram below presents. 
 
 
Figure 2. Mechanical landscape of the cell. (A) Integrin-based focal adhesions. (B) Cadherin-
dependent adhesive junctions. (C) Contractile actin–myosin network. Adapted from (Mui, Chen and 
Assoian, 2016). Reprinted with permission from the publisher. 
 
1.1.1 Cell-Matrix Adhesion 
Cell attachment to the surrounding ECM components with specialized structures is termed 
“cell-matrix adhesion.” 
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1.1.1.1 ECM components 
The ECM forms the complex niche of structural elements that surround cells in vivo, and is 
commonly known as connective tissue in animals. It provides structural and biochemical 
support for the cell anchorage required for cell morphogenesis, mobility and differentiation. 
In return, the cells that sense the environmental stimuli are also capable of deforming and 
remodeling ECM in response.  
Fundamentally, the ECM consists of water, polysaccharides and approximately 300 proteins, 
and the composition and properties of ECM is tissue-specific and also strikingly 
heterogeneous. Proteoglycans (PGs) and fibrous proteins are the two main classes of 
macromolecules comprising ECM. Proteoglycans form a hydrated gel-like network filling the 
interstitial space and regulating tissue properties and cell binding to ECM (Schaefer and 
Schaefer, 2010).  Collagens, presenting as fibrous protein, are the most abundant protein in 
ECM, and give structural support to surrounding cells. Elastin, by contrast, gives elasticity to 
tissues as bungee that allows stretching when needed. Tissues such as blood vessels and skin 
contain high amounts of elastin in order to absorb mechanical stress. For instance, the 
degradation of elastin in aortic wall is one of the most common predisposing factors for aortic 
dissection, since the stiffer wall is not able to sustain the pulsatile blood flow (Tsamis, 
Krawiec and Vorp, 2013). Collagen and elastin are closely associated and the delicate balance 
of their stoichiometry determines ECM stiffness and elasticity (Bonnans, Chou and Werb, 
2014).  
Fibronectin (Fn), another large fibrous protein (450 kD), not only is involved in organizing 
interstitial ECM, but also plays a key role in mediating cell adhesions. The protein consists of 
homologous repeating structural motifs termed type I, II, and III modules, which contains 
binding sites for cells, collagens, and other ECM partners (Figure 3). The motif in FnIII 
binding cells through integrins is a tripeptide called Arg-Gly-Asp (RGD). 
 
Figure 3. Fn’s major binding sites. The primary structure of Fn, displayed with binding sites to 
different proteins. Adapted from open-access article (Kubow et al., 2015), which was the modified 
version of  Figure 1 in (Antia et al., 2008). Reprinted with permission from the publisher. 
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Both in vitro and in vivo evidence has supported that Fn exhibits specialized structural states 
subjected to cellular forces within ECM (Chandler et al., 2011; Cao et al., 2012). Cell-
mediated Fn fibril assembly is tightly regulated by mechanical signals (Zhong et al., 1998). 
The traction generated by cells is sufficient to extend the fibers at least 5-6 fold through 
multiple modules unfolding (Little et al., 2008). These conformational changes can expose 
the cryptic sites, which remain hidden under circumstances characterized by low mechanical 
stress. Additionally, the exposure of cryptic sites in FnIII, for instance, is an activator and 
regulator for integrin binding and cell signaling affecting cytoskeleton formation and 
organization (Smith et al., 2007). Conversely, a change in cytoskeleton contractility is able to 
alter the same FnIII cryptic sites. Manipulating cell contractility by inhibiting actomyosin 
contractility using cytochalasin D or Rho A inhibitor caused the similar remolding of FnIII in 
fibrils in vitro (Baneyx, Baugh and Vogel, 2002). 
1.1.1.2 ECM stiffness 
Because the specific composition of ECM is organ-dependent, different tissues display 
varying levels of stiffness, from the soft tissue of the lungs (≈200 Pascals, Pa in short) and 
breast (≈800 Pa) to that of muscle (≈12, 000 Pa) and bone (2-4 x 109 Pa) (Butcher, Alliston 
and Weaver, 2009). Collagens are the major contributors to the physical properties of a tissue 
due to its abundance and intricate glycosylation and crosslinks with other fibrous proteins, 
such as elastin and Fn (Erat et al., 2013). However, the collagen matrix could not form in an 
Fn-deficient fibroblast cell culture without exogenous Fn (Velling et al., 2002). In addition, 
defective Fn has contributed to stiffer ECM due to massive collagen deposition in a mouse 
model (Iwasaki et al., 2016). These findings indicate that Fn is a critical regulator of ECM 
stiffness. 
An uncontrolled increase in the cross-linking between Fn and collagen proteins can lead to 
more ECM rigidity, whereas too little communication results in ECM degradation. Both 
perturbations can cause a number of tissue behaviors to go awry, eventually leading to severe 
disease, such as fibrosis or cancer (Najafi, Farhood and Mortezaee, 2019). Changes in ECM 
stiffness can occur in very early stages. Therefore, early detection and reversal of abnormal 
ECM properties is important in the diagnosis and treatment of disease.  
1.1.1.3 Integrin associated focal adhesion 
How are mechanical cues transmitted into the cell?  
Cells form force-sensitive integrin-containing protein complexes called focal adhesion (FA) 
at the interface between intracellular actin bundles and the extracellular substrate. Focal 
adhesion is distinguished from other adhesive structures for its response to tension as seen in 
Table 1. Focal adhesion assembly and disassembly can be highly dynamic depending on the 
mechanical instruction from both sides of the cell membrane (Zamir et al., 2000). Thus, FAs 
are generally considered to be the mechanosensory units that integrate multiple 
spatiotemporal cues and interpret into pathways controlling cellular decisions. 
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Table 1. Terms regarding cell-matrix adhesions. Summarized from (Sun, Lambacher and Fässler, 
2014; Truong and Danen, 2009). 
 
The major bi-directional signaling receptors are integrins. In the 1980s, Hynes and colleagues 
first cloned a cell membrane protein, which was found to be the major adhesion receptor and 
subsequently named integrin (Tamkun et al., 1986). Integrins function as heterodimeric 
glycoproteins with an α- and a β-subunit. So far 18 integrin α-subunit genes and 8 integrin β-
subunit genes have been discovered in humans, generating 24 known binding pairs as integrin 
heterodimers (Takada, Ye and Simon, 2007). They exhibit distinct specificity in binding 
diverse matrix molecules, for instance, Fn, fibrinogen, collagen, laminin et cetera. 
Integrin activity is modulated by changes in ligand affinity (low, intermediate and high), both 
spatially and temporally (Luo, Carman and Springer, 2007). With respect to structure, 
integrin activation can be recognized by the complete extension or separation of the 
cytoplasmic leg domains. The mechanical signals generated by integrins can modulate cell 
adhesion dynamics and influence both cell functions and ECM remodeling (Ginsberg, 2014). 
When the cells are stimulated to migrate in processes such as wound healing, angiogenesis, 
the cells frequently generate and deform the anchorages on ECM mediated by a specific 
profile of integrins (which integrins are involved and if the integrin is activated, for example). 
Truong’s team has proposed an “integrin switch” theory in Fn-binding of α5β1- and αvβ3-
integrin, in which a shifted integrin profile can dramatically affect the FA dynamic and cell 
motility (Truong and Danen, 2009). 
1.1.1.4 Proteins associated with FA 
Integrins recruits more than 180 proteins to FAs, including FA structural adaptors, 
scaffolding and catalytic adaptors et cetera. Classically, talin and vinculin are well-known 
mechanosensitive proteins (Rio et al., 2009; Grashoff et al., 2010), both of which are crucial 
for stabilizing FAs and engaging contractile actin filaments. Talin is a multi-domain protein 
that contains binding sites for the integrin cytoplasmic domain in the N-terminal as well as 
for F-actin binding sites in the C-terminal (Calderwood, Campbell and Critchley, 2013). In 
the relaxed state, talin’s cryptic sites are not exposed for binding; however, cytoskeleton 
contraction stretches talin to unfold vinculin-binding sites. Activated vinculin stabilizes the 
open conformation of talin to enhance the mechanical connection between integrin and the 
actomyosin cytoskeleton (Yao et al., 2014a). Additionally, paxillin have been demonstrated 
to primarily form bridges for FA proteins to physically attach to (Schaller, 2001); in another 
way, focal adhesion kinase (FAK) is able to amplify the signals transduced from FAs by 
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phosphorylation on cytoplasmic tail residues in response to integrin engagement and other 
stimuli (Deramaudt et al., 2011).  
1.1.2 Cell-Cell adhesion 
Cells in vivo are not only attached to ECM, but also closely glued to adjacent cells via cell-
cell contacts. Stable adhesion between cells contributes to the integrity of the tissue, while 
dynamic cell-cell adhesions provides molecular basis for development of multicellular tissue 
architecture and morphogenesis (Gumbiner, 1996). Besides providing physical attachment, 
adhesive structures also enable intercellular communications of mechanical, chemical, or 
electrical signals. So far there are several types of cell-cell adhesive junctions that have been 
reported to be sensitive and responsive to mechanical force: 
1.1.2.1 Adhesion Junction (AJ) 
An AJ is a stable cell anchoring that serves as an interconnected lateral bridge linking that 
contractile actin cytoskeleton of one cell to that of another. The core AJ components are the 
cadherin (named for “calcium dependent” adhesion), which bind cell together. Classical 
cadherins are cell-type specific; for example, E-cadherin (Cdh1) is found in epithelial tissue, 
VE-cadherin (Cdh5) in vascular endothelium and N-cadherin (Cdh2) in neurons and 
mesenchymal cells, such as pericytes and fibroblasts. Depending on contacts occurring 
between identical or different cell types, AJs can be described, respectively, as either 
homotypic or heterotypic. For example, endothelia form the luminal surface by VE-cadherin 
between cells, but form N-cadherin based contact with mural cells (e.g., pericyte).   
Initial clues that AJs respond to mechanical force were derived from the observation that AJ 
size and strength can be altered by mechanical force (Liu et al., 2010; Thomas et al., 2013). 
More directly, using magnetic twisting cytometry to apply force to E-cadherin, cell adhesions 
were stiffened (le Duc et al., 2010). With the knowledge of cadherins probing and 
transmitting mechanical force, extensive studies have focused on the cytoplasmic 
components that mediate the force to the cytoskeleton. β-catenin is one the most important 
linker proteins and has been identified to not only bind E-cadherin intercellular domains, but 
also to directly couple to α-catenin and vinculin, both of which link to the actin cytoskeleton 
(McCrea, Turck and Gumbiner, 1991; Jockusch and Isenberg, 1981). 
1.1.2.2 Tight junction (TJ, also known as zonula occludens) 
Tight junctions are intercellular junctional complex formed in epithelium and endothelium 
that make up the epithelial and endothelial diffusion barriers (Steed, Balda and Matter, 2010). 
The components of TJs are initially recruited to cadherin-based AJ and are thereafter 
relocated to the distinct apical side of the cells as junctions mature. Topologically, TJs are 
closely intermingled with AJs, especially strong in endothelium (Dejana, 2004). In addition to 
functions of maintaining cell polarity and preventing the leakage of ions and solutes, the 
relationship between TJ biology and mechanical force has begun to be noticed (Citi, 2019). 
The common integral membrane proteins include transmembrane proteins (claudin, occludin 
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and tricellulin) and single-span transmembrane proteins, such as junctional adhesion 
molecules (JAMs). Similar to AJs, the cytoplasmic scaffold proteins at TJs interact with 
cytoskeleton through the cytoplasmic scaffold proteins such as ZO (zonula occludens)-1, 
MAGI-1 (membrane-associated guanylate kinase inverted proteins) and polarity proteins 
PAR-3, PLLS-1 and PATJ (Zihni et al., 2016; Fanning, Itallie and Anderson, 2012).  
1.1.2.3 Desmosome (also known as macula adherens) 
Desmosomes adopt a hyper-adhesive manner to resist mechanical stress as intercellular 
junctions. Instead of association via dynamic actin filaments, cadherin-like transmembrane 
and linker proteins form strong scaffolding poles with keratin intermediate filament, termed 
DIFC (desmosome-intermediate filament complex). This firm structure strengthens cell-cell 
binding, which is pivotal for tissue integrity, but with less ability to adjust transient and 
temporal mechanic cues (Garrod and Chidgey, 2008). Desmosome structures are commonly 
found in epithelia and cardiac muscle, but not in endothelium (Dejana, 2004).  
1.1.2.4 Gap junction (GJ) and ion channel 
Gap junctions are specialized intercellular connections between the cytoplasm of two cells, 
functioning as a regulated gate that selectively permits the direct passage of small molecules. 
These connexin-based channels are able to react with mechanical forces in vascular tissues 
and bones (Salameh and Dhein, 2013). For instance, the three-fold up-regulation of Cx43 
(one of the connexin proteins), together with an enlarged GJ size, has been observed within 
four hours of cyclic mechanical stretch on cultured rat cardiomyocytes (Wang, Tseng and 
Chang, 2000). An ion channel is another type of spot-like structure between two attaching 
cells that permits the direct transportation of small ion molecules such as K+ and Na+, 
Notably, ion channels have also been reported as a mechanosensor of substrate rigidity 
through stress fibers and FAs (Kobayashi and Sokabe, 2010). 
1.1.3 Cytoskeleton network 
After the mechanical force comes through the surface-adhesion receptors, such as integrins 
and cadherins, the stress either dissipates quickly to the viscous cytoplasm or continues 
passing through channels with certain tensegrity. The solid network built to maintain cell 
structure is termed the cytoskeleton, and it is the fundamental structure inside cells to mediate 
the force transmission (Wang, Butler and Ingber, 1993). The cytoskeletal proteins can be 
divided into three main groups. 
1.1.3.1 Intermediate filament (IF) 
Averaging 10 nm in diameter, IFs are the stable and durable structure protecting the cell from 
external mechanical stress, anchoring organelles and composing nuclear laminas. As 
mentioned earlier, IFs are one of the components of DIFC (desmosome-intermediate filament 
complexes) at desmosomes connecting to neighboring cells. There is a high diversity of IF 
expression depending on cell type: Keratins are primarily expressed in epithelial cells, and 
desmin in muscle cells, for example. Vimentin is generally expressed in mesenchymal cells 
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and endothelial cells (ECs). In addition, vimentin is expressed and various tumor cells, and 
the up-regulation of vimentin is one among several markers for epithelial to mesenchymal 
transition (EMT) (Mendez, Kojima and Goldman, 2010).  
1.1.3.2 Microtubule (MT) 
Microtubules are hollow cylinders of about 23 nm in diameter and consist of polymers of α/β-
tubulin. They are essential to several cell processes, such as cell division, the transportation of 
cellular molecules, organelle distribution and cell mobility. Due to the relative rigidity of 
MTs, the cycles of polymerization and de-polymerization inherent to MTs could actually 
generate a push or pulling force through the dynamically extending or shrinking MT “tip” 
(Kent and Lele, 2017).  
1.1.3.3 Actin filaments (AFs, also known as microfilaments) 
Actin is the main component of the highly dynamic AF structures. Globular (G)-actin 
monomers combine as a linear polymer and continue to assemble into two intertwined chains 
called filamentous (F)-actin. AFs either connect with other AFs to form a bundle, or together 
with the motor proteins, such as myosin superfamily, to generate a network known as an actin 
cytoskeleton. The actin cytoskeleton facilitates the transmission and transduction of 
mechanical signals and at the same time, can generate intracellular tensions required for cell 
motility, muscle contraction, cell signaling and so on. This contractile property is supported 
by motor proteins, which exhibit distinct individual characters, as they are not only able to 
translocate along AF, but also induce the movement of AF itself.   
Myosin II is the only member that can form polymeric assemblies with F-actin (Cheney, 
Riley and Mooseker, 1993). In skeletal muscle cells, myosin II forms strong thick-filaments 
to generate powerful contraction along with other proteins, however in non-muscle cells, 
myosin II associates with AFs to form “thinner” contractile actin bundles, called stress fibers 
(actomyosin fibers) (Kreis and Birchmeier, 1980). Stress fibers consist of connecting or 
connected to FAs, in which a cell attaches to the substrate in a highly regulated and dynamic 
manner, and they therefore contribute to a number of functions, such as cell migration and 
morphogenesis
 
As seen in Figure 4, F-actin grows from the 
organization of G-actin monomers, which can 
be blocked by a polymerization inhibitor such 
as cytochalasin D (May et al., 1998). The 
contraction force generated from myosin-actin 
can be abolished by the myosin II inhibitor 
blebbistatin (Straight et al., 2003). 
 
Figure 4. Schematic of inhibition of myosin-actin contractility. Adapted and modified from (Chen et 
al., 2010). Reprinted with permission from the publisher. 
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Unlike the well-documented dynamic organization of AFs in the cytoplasm, the regulation 
and function of the nuclear AF has recently been highlighted (Grosse and Vartiainen, 2013). 
A recent study revealed that physiological ligands for G protein-couple receptors (GFCRs) 
and Ca2+ elevation promoted nuclear F-actin assembly and altered chromatin dynamics 
(Wang et al., 2019).  
1.1.3.4 Rho signaling pathways 
The Rho family of GTPases is one of the key mediators of the mechanical forces exerted on 
integrins and cadherins (Lessey, Guilluy and Burridge, 2012; Noren et al., 2001). In this 
context, RhoA, Rac1, and Cdc42 have been intensively studied for their characteristic roles in 
actomyosin contraction (Arnold, Stephenson and Miller, 2017). RhoA cycles between GDP 
state (inactive) and GTP state (active). Rho-GTP are regulated via GEFs (guanine exchange 
factors) and GAPs (GTPase activating proteins) (Jaffe and Hall, 2005). The activation of 
RhoA positively affects mDia (mammalian homologue of Drosophila diaphanous, a formin 
protein) to directly nucleate and polymerize long AFs (Narumiya, Tanji and Ishizaki, 2009). 
Furthermore, Rho-GTP activates ROCK (Rho-associated coiled-coil forming kinase), which, 
in turn, phosphorylates the myosin light chain (Kimura et al., 1996). RhoA thereby promotes 
the formation of the stress fibers crossing FAs, as well as cell-cell junctional tension (DeMali, 
Sun and Bui, 2014; Ratheesh et al., 2012). Moreover, both Rac1 and Cdc42 are regulated by 
Rho GEFs and activate the arp2/3 complex through WAVE and N-WASP respectively, 
thereby promoting actin polymerization (Spiering and Hodgson, 2011). Cdc42 has been 
implicated as promoting the formation of the filopodia of migrating cells, while Rac1 has a 
greater role in lamellipodia formation. 
Mechanical forces can trigger multiple signaling pathways, many of which result in 
regulating the activation of the GTPase RhoA, especially when the forces are relayed via cell 
adhesive molecules (Lessey, Guilluy and Burridge, 2012). A biphasic regulation of RhoA 
activity has been uncovered in ECs when subjected to flow in vitro: RhoA was inhibited 5–10 
minutes after the shear stress was applied, but was gradually activated after 30 minutes 
(Tzima, 2006). Another example supporting the notion is that a more active form of RhoA 
was detected in cells subject to tensional stress produced by magnetic tweezers and applied 
perpendicularly (Zhao et al., 2007). In addition to forces applied externally, the myosin-
dependent contractility generated by cells adjusting to different ECM rigidity have an impact 
on RhoA activation (Wozniak et al., 2003). 
1.1.4 Force impact on nuclei 
In 1997, the Ingber group discovered the molecular connection among integrins, F-actin and 
nuclear scaffolds as a systemic path for mechanical force transmission. From these and more 
recent data it is becoming increasingly clear that the nucleus is not only a storage site for 
hereditary information, but is also a rheostat that regulates mechanical strain (Maniotis, Chen 
and Ingber, 1997).   
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The mechanical force exerted on the integrins and cadherins on the cell surface is able to 
travel along the contractile cytoskeleton to be transmitted into distant a cytoplasm and 
nucleus, as shown in Figure 5 (Wang, Tytell and Ingber, 2009). Compared to chemical signal 
propagation, a physical “stress wave” is 40 times more time efficient in provoking a nuclear 
response (Na et al., 2008).  
 
Figure 5. Molecular connectivity from the ECM to the nucleus. A local force exerted on integrins 
from the ECM is concentrated at focal adhesions and conveyed to F-actin filaments. F-actins are 
connected to Nesprin 1 and 2 of the inner nuclear membrane protein SUN1/2. SUN-proteins directly 
bind to the lamins that form the lamina and nuclear scaffold, which affects chromatin and DNA 
organization and gene activation. The force channeled into the nuclear scaffold might take 
milliseconds. By contrast, it takes seconds for the chemical diffusion of growth factors to alter nuclear 
shape and function. Adapted from (Wang, Tytell and Ingber, 2009). Reprinted with permission from 
the publisher. 
 
1.1.4.1 Nuclear shape and positioning  
When a certain force is exerted through the cytoskeleton onto the nucleus, whether from 
contractile energy for migration or tensions from adjacent cells, nuclear properties generally 
respond in two manners: to deform or to move.  
Depending on the cell type, the cell cycle stage, the migratory stage and differentiation status, 
nuclear shape can differ dramatically (Gundersen and Worman, 2013a); however, in most 
cases, nuclear shape coincides with the shape of the cell. Direct evidence came from an 
observation that ECs on an elongated pattern forces the elongation of the nuclei (Versaevel, 
Grevesse and Gabriele, 2012). This suggests a mechanical model, in which stress fibers 
induced by force orient the cell along the force direction and therefore elongate the cell 
nucleus. The rounding of the cell shape that is induced by drugs that inhibit myosin II activity 
   11 
or actin filament formation can also result in the rounding of the nuclei (Buxboim et al., 
2017). 
The position of nuclei in cells is regulated by cell geometry and activity. When the nucleus 
remains in a stationary position, the forces acting on it reach a balance. A number of studies 
have shown in vitro that cell positioning can be altered by a disrupted force balance on the 
nucleus, manipulation of cytoskeletal contractility and the mutation of the nuclear anchoring 
proteins, as reviewed in (Lele, Dickinson and Gundersen, 2018; Gundersen and Worman, 
2013b). 
1.1.4.2 The cellular nucleus responds to mechanical forces 
Similarly to the outer cell membrane, which forms a physical boundary permitting the 
transfer of bio-chemical and -mechanical signals, the nuclear lamina separates the cytoplasm 
from the nucleoplasm (Gruenbaum and Medalia, 2015; Butin-Israeli et al., 2012). The 
nuclear membrane incudes proteins that connect to the cytoskeleton as well as proteins that 
regulate mRNA and protein transport. The proteins involved in nuclear positioning and 
mechanotransduction are described below. 
The linker of nucleoskeleton and cytoskeleton (LINC) complex, similar to FAs and AJs at the 
outer membrane, functions as a bridge through which mechanical signals can pass into the 
nucleus. This physical attachment to the cytoskeleton ensures proper nuclear shape and 
subcellular nuclear positioning (Lee and Burke, 2018; Hieda, 2019; Gundersen and Worman, 
2013a). The LINC complexes are comprised of nuclear envelope spectrin repeat proteins 
(Nesprins) located on the outer nuclear surface and SUN proteins (Sad1/UNC-84) at the inner 
the nuclear membrane. The cytoskeleton in cytoplasm is therefore able to physically couple 
with lamins and chromatin inside nucleus through SUN/Lamin A and Nesprin/Actin 
associations (Starr and Han, 2002; Haque et al., 2006; Starr and Fischer, 2005).  
Lamins, such as Lamin A/C (two isoforms coded by gene LMNA) and Lamin B cover the 
interior of the nuclear envelope. They are a type V intermediate filament and thus, 
structurally support the nucleus in resisting mechanical perturbations. Dramatic changes in 
the nucleus is the hallmark of LMNA genetic mutations that leads to laminopathies, such as 
Hutchinon-Gilford progeria syndrome (Gonzalo, Kreienkamp and Askjaer, 2017). Moreover, 
nuclear stiffness is determined by the relative levels of Lamin A/C. It was recently shown that 
the stiffness of the individual organ also determines nuclear stiffness by regulating LMNA 
levels (Swift et al., 2013).    
Interestingly, chromatin have been proposed to function as a physical spring to push or pull 
against nuclear deformation, depending on a restoring force generated by linker DNA and 
nucleosome interaction via histone tails (Maeshima, Tamura and Shimamoto, 2018).  
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1.1.5 YAP is a mechanoresponsive transcription factor 
Yes-associated protein (YAP, also known as YAP1 or YAP65) and the transcriptional co-
activator with PDZ-binding motif (TAZ) are downstream effectors of the Hippo pathway. 
YAP activity is tightly regulated by the MST1/2 kinases, which can trigger phosphorylation 
and activation of LATS1/2 kinases, which further phosphorylate and inactivate YAP and 
TAZ, thus preventing nuclear relocation (Gaspar and Tapon, 2014). Most of YAP/TAZ 
transcription targets are associated with cell proliferation, and the activity of Hippo molecules 
in the nucleus has therefore been associated with organ growth and tumor progression 
(Zanconato et al., 2015). Remarkably, recent studies have revealed a rheostat of mechanical 
force; that is, YAP is able to directly promote the transcription of genes related to ECM 
composition, cell–ECM communication and cytoskeletal integrity (Nardone et al., 2017; 
Morikawa et al., 2015). 
In response to the mechanical cues from ECM or cells in their vicinity, YAP/TAZ can 
translocate into the nucleus to activate the specific transcription factors and thereby affect 
gene expression. More specifically, when the cells are mechanically activated by a large 
adhesive area, stiff substrate, low cell density, disturbed flow and stretching of the confluent 
monolayer, YAP/TAZ enter the nucleus to regulate gene expression (Panciera et al., 2017). 
Thus, YAP/TAZ not only sense the mechanics but also mediate the biological effect in 
different biological contexts by modification on transcriptome, for example neuronal 
differentiation, apoptosis et cetera. 
Moreover, YAP/TAZ-based mechanotransduction demands the integrity of the actin 
cytoskeleton. At least in in vitro experiments, YAP/TAZ activity is decreased by F-actin 
inhibition (Dupont et al., 2011; Morikawa et al., 2015; Piccolo, Dupont and Cordenonsi, 
2014).  
There is increasing evidence for the clinical importance of the proper control of 
mechanotransduction: Genetic mutations of the key molecules and aberrant activation of 
relevant signaling pathways may lead to severe clinical problems, such as fibrosis, 
myopathies and cancer (Jaalouk and Lammerding, 2009). Strikingly, many of these defects 
may be directly or indirectly caused by the deregulation of YAP/TAZ (Panciera et al., 2017).  
Endothelial cells are intimately exposed to mechanical forces generated by blood flow and 
alteration in mechanical parameters may directly initiate the vascular pathogenesis (Hahn and 
Schwartz, 2009). Normally, YAP/TAZ are inhibited in ECs that are cultured under laminar 
flow. However, disturbed shear stress activates the YAP/TAZ and JNK (c-Jun N-terminal 
kinase) signaling pathway, and thus up-regulates a number of pro-inflammatory genes whose 
expression results in atherosclerosis (Wang et al., 2016b).  
Tissue fibrosis may occur in the liver, lungs, kidneys and other organs. This is characterized 
by excessive stiffness in ECMs by over-activated fibroblasts (or myofibroblasts) over a 
certain time. In liver fibrosis, the activation of YAP in hepatic cells results in liver damage 
(Mannaerts et al., 2015). In idiopathic pulmonary fibrosis, YAP/TAZ activity maintains a 
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pro-fibrotic regulation of transcriptome on lung fibroblasts, which increases the Fn and 
collagen deposition (Jorgenson et al., 2017). 
Finally YAP/TAZ pervasive activation has been uncovered in various human cancers, 
which results in massive proliferation, drug resistance and metastasis (Piccolo, Dupont and 
Cordenonsi, 2014; Zanconato, Cordenonsi and Piccolo, 2016).  
1.1.6 Force measurement and manipulation 
Whether the mechanical forces are generated from cell–ECM or cell–cell junctions, the 
subcellular forces that are relayed are as minute as in picoNewton (pN) range. For instance, 
80–300 pN is necessary to unfold Fn type III domain (Oberhauser et al., 2002), and the forces 
generated by growing microtubules, F-actin-binding myosin motors and microtubule-binding 
motor proteins only require 3–7 pN (Cost et al., 2015). Despite apparent difficulties in 
measuring the forces in vivo, a number of approaches have been developed to scrutinize 
cellular mechanical tension in living cells in vitro (Ungai-Salánki et al., 2019; Roca-
Cusachs, Conte and Trepat, 2017). Due to space limitation, this section only focuses on 
several well-established and representative approaches.  
1.1.6.1 Force sensors based on known material 
“Cantilevers”- based methods 
These systems apply cantilevers with a known stiffness to the bottom layers and allow cells 
or tissue to grow on top. Simply speaking, the more the cells contract, and the harder those 
cantilevers bend. By measuring the observed displacements of the free end of pillars, we can 
calculate the contractile energy and force (Polacheck and Chen, 2016). The micro-pillars can 
be made of a variety of materials, such as magnetic beads, molecules and collagen, among 
which traction force microscopy (TFM) employs fluorescent beads emerged in Fn-coated 
elastic substrate for cells to grow on. To date, TFM has improved its accuracy and spatial 
resolution dramatically and become one of the most extensively used methods of measuring 
cell–ECM contractile force (Plotnikov et al., 2014).  
Surface Plasmon Resonance Microscopy  
Surface plasmon resonance (SPR) microscopy is an approach for cell–substrate contacts of 
cells in culture based on the optical excitation of surface plasmons (Giebel et al., 1999). 
Without any pre-engineering, cells are cultured on the coated glass prism with a laser beam in 
below. The evanescent field generated by the electromagnetic wave can be interfered by the 
cells, so that the intensity of reflected light changes corresponding to the distance between 
cell and substrate, and this can be correlated to the local force.  
Förster resonance energy transfer-based tension sensors 
Förster resonance energy transfer-based tension (FRET) sensors offer an excellent tool for 
mapping the force distribution inside living cells with high resolution (Grashoff et al., 2010). 
In brief, the FRET sensor is recombined into a specific protein in a transgenic cell type, and 
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another gene is constructed to express two fluorophores with an elastic linker. Once the force 
exerted, the linker would extend like a spring under force, and in this way the change in 
distance between fluorescent proteins can be captured by fluorescent microscopy.  
1.1.6.2 To apply force exogenously 
From another perspective, researches, both biologists and physicists, have been developing 
systems to actively manipulate the force applied to the cells and observe or measure the cell 
response.  
Flow chambers 
Aiming to recapitulate the in vivo physiological/pathological flow condition in vitro, we often 
apply external shear sheer on ECs in vascular biology research. The Ibidi flow system 
includes the advantages of various flow conditions, ease of operation, minimal external 
supply needed and possibilities for more applications.  
Forces applied by physical stretching or touching  
The stretchable/elastic culture substrate provides a useful tool to access the cell resistance 
against external strain. The cells are cultured on a stretchable substrate, which enables 
artificial straining and relaxing of the elastic membrane.  
Atomic force microscopy (AFM), micropipette aspiration, microplate, magnetic and optical 
tweezers apply force directly through specifically coated beads or a “tip” on the cell 
membrane or subcellular structures. They are useful for either probing the cellular reaction to 
physical stimuli or measuring exact mechanical quantity (Sugimura, Lenne and Graner, 
2016).  
1.1.6.3 Cell itself as a sensor  
Instead of “human-made” force sensors, a “cell-made” device, to some extent, provides more 
“natural” and dynamic data. Those sensors require a known property and exhibit noticeable 
conformational changes on force application (Roca-Cusachs, Conte and Trepat, 2017). 
Molecular conformational changes include an unfold-fold switch, domain re-orientation, the 
opening of ion channels et cetera (Ehrlicher et al., 2011; Yao et al., 2016; Wu, Goyal and 
Grandl, 2016). With the help of approaches that precisely manipulate the force, many protein 
conformational changes have been identified. For example, the application of external forces 
induced the stretching of single talin rods, which unmasked cryptic binding sites that 
permitted vinculin binding (Rio et al., 2009). Similarly, it has been reported that force could 
induce a conformational switch of α-catenin, which activated vinculin binding (Yao et al., 
2014b). Moreover, based on the known conformation changes of force-sensitive molecules, 
external probes can be designed to distinguish those changes as a “force detector.” Krieger 
and colleagues labeled cysteine residues and found that this cysteine labeling in several 
proteins, changed by mechanical input in living cells (Krieger et al., 2011).  
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1.2 Mechanical force in vascular development 
During vascular development, the endothelium, which forms the inner layer of blood vessels, 
relentlessly encounters numerous and varied mechanical forces derived from ECM, 
interactions with adjacent cells, pulsatile flowing blood and extravasation of cells from 
flowing blood (Figure 6). How ECs sense and respond to those mechanical inputs is essential 
for new blood vessel formation, vessel maturation and eventually a functioning blood vessel 
network. 
 
Figure 6. ECs subjected to physical forces. ECs feel the force from the ECM, cell-cell junction and 
direct encounter of the shear stress from pulsatile flow. Adapted and modified from (Uhler and 
Shivashankar, 2017). (Uhler and Shivashankar, 2017). Reprinted with permission from the publisher. 
1.2.1 New blood vessel formation 
New blood vessels are formed by three different mechanisms: 1) Vasculogenesis: This is 
involved in the establishment of the first primary vessels during embryogenesis. In this 
process, the aorta and the cardinal vein are formed by the differentiation of EC from 
mesoderm progenitor cells. 2) Intussusception: The capillary wall extends into the lumen and 
thus splits a single vessel into two. 3) Angiogenesis: This process describes the formation of 
blood vessels from the pre-existing ones. More specifically, vascular growth involves tip cell 
selection, migration, stalk cell proliferation, and ultimately vascular stabilization. 
Uncontrolled angiogenesis precedes a wide spectrum of vascular pathologies such as kidney 
disease, cardiovascular complications, autoimmune syndromes et cetera. Angiogenesis is also 
a hallmark of cancer progression as the growing tumor is in increasing demand of nutrients 
and oxygen to expand beyond a limited size of 500 µm in diameter.  The hypothesis that 
tumor angiogenesis can be targeted as a cancer therapy was proposed by Judah Folkman in 
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1971 (Folkman, 1971). Since then, anti-angiogenic therapies have entered the clinic, though 
with only modest clinical efficacy.  
1.2.1.1 Force transmission during angiogenesis 
During angiogenesis, ECs migrate in a directional manner guided by growth factors. 
Migration involves the separation of EC into tip cells and stalk cells. As its name suggests, 
the endothelial tip cell is a specialized EC that leads to and guides the endothelial sprout. 
They are highly polarized with numerous extended protrusions (termed filopodia) to sense 
and probe the environment. These filopodia not only detect and respond to chemotactic 
factors such as vascular endothelial growth factor (VEGF)-A and axon guidance factors but 
also mechanically interact with the surrounding ECM. The ECM exerts mechanical control 
on the endothelium via integrin-based FAs that relay forces to the cellular cytoskeleton 
(Hynes, 2002; Schwartz, 2010b). These FAs bridge the cytoskeleton and ECM resulting in 
stress fibers of myosin-actin filaments pulling the cell forward (Lamalice, Le Boeuf and 
Huot, 2007). 
Fn is a major component of the ECM. Among many alternatively spliced variants of Fn, the 
exons EIIIB (between Fn repeats III7 and III8) and EIIIA (III11 and III12) are strongly 
associated with vascular remodeling (Pankov and Yamada, 2002). Fn containing these two 
domains is highly expressed in newly formed vessels during angiogenesis, but it is barely 
detectable in mature vessels in adults (Murphy, Begum and Hynes, 2015). The Fn-binding 
endothelial integrins α5β1- and αvβ3/β5-integrin receptors are up regulated in newly forming 
vessels and are therefore considered anti-angiogenic targets. However, the mechanisms 
whereby these molecular pathways control angiogenesis are complex (Alday-Parejo, Stupp 
and Rüegg, 2019). Inactivation of integrin α5 and αv during mouse development causes death 
in utero due to vascular defects (Murphy, Begum and Hynes, 2015). Although highly 
expressed in tumor endothelium, conditional deletion of Fn, α5β1 and αvβ3/β5 does not have 
a satisfactory outcome in inhibiting tumor expansion (Murphy, Begum and Hynes, 2015), 
which suggests the up-regulation of alternative compensatory pathways. Indeed, analysis of 
the integrin adhesome has identified over 180 proteins, some of which are regulated by actin 
tension (Zaidel-Bar and Geiger, 2010; Schiller et al., 2011). Further insight into how 
mechanical forces are transduced may develop a better understanding of the mechanisms of 
endothelial tip cell migration during angiogenesis. 
1.2.1.2 EC-perivascular cell interaction  
Endothelial cells are the primary building block of blood vessel construction, however it is 
insufficient for ECs to from functional vasculature independently. When the vessel sprouts 
fuse with neighboring ones to form capillary loops, they require help from other supporting 
perivascular cells, such as smooth muscle cells and pericyte.  
Vascular smooth muscles cells commonly support larger arteries and veins by wrapping the 
vessels in a circumferential manner. In contrast, pericyte characterized by an elongated and 
flattened shape, specifically embrace ECs at smaller capillaries. By multiple projections 
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covering the surface of ECs, pericyte form direct contact to EC in addition to paracrine 
signaling communications. Adhesion plagues anchoring pericyte to ECs are centered by the 
N-cadherin associated complex, which enables transmission of mechanical contractile force 
in between (Gerhardt, Wolburg and Redies, 2000).  
Platelet derived growth factor (PDGF) is released primarily by ECs and activates the PDGF 
receptor β (PDGFR-β) on pericytes, among other perivascular cells. Genetic ablation of 
PDGF or PDGFR-β in mice causes embryonic death due to dysfunctional vasculature with an 
enlarged, highly permeable and dilated morphology (Lindahl et al., 1997). Poor coverage of 
pericyte on ECs was observed histologically, as was EC hyperplasia, which supports the 
notion that pericyte plays a key role in stabilizing developing vessels and preventing ECs 
from redundant angiogenesis (Gerhardt and Betsholtz, 2003). 
1.2.2 The cardiovascular system 
In the human body, the cardiovascular system consists of the heart, blood vessels and 
approximately five liters of blood. Most, if not all, organs are dependent on this organized 
circulatory system, which is responsible for the transport of oxygen and nutrients.  Regardless 
of vessel type, endothelium undergoes multiple mechanical forces that are exerted on the 
vessel wall (radial, circumferential and longitudinal forces) or on the endothelial surface 
(shear stress). However the magnitude of those forces varies across a wide range on arteries 
and veins; for example, the aorta sustains 10-fold more shear stress (dyn/cm2) on average 
than the vena cava (Givens and Tzima, 2016). In return, ECs in arteries and veins exhibit 
distinct morphological and functional differences in response.  
1.2.2.1 Artery and vein 
Arteries, in general, are smaller in diameter than veins but mostly show much thicker vessel 
walls. The innermost layer of the vessel is the tunica intima (intima for short), which contains 
endothelium and a supportive matrix composed of collagen and elastin. The elastic fibers 
form a specialized internal elastic lamina in arteries, especially abundant in larger ones such 
as the aorta. This lamina provides reversible elasticity that allows large arteries to expand and 
relax with the cardiac cycles (Cocciolone et al., 2018).  
Aside from wall structure, distinct morphological differences exist between arterial and 
venous ECs: Arterial ECs are elongated and aligned in the direction of laminar flow, while 
venous ECs exhibit a more rounded phenotype. Furthermore, veins are more vulnerable to 
inflammation and leukocyte trafficking, especially in the post-capillary venules (dela Paz and 
D’Amore, 2009).   
1.2.2.2 Hemodynamics of the aorta 
The aorta is the main artery in the body and thus exposed to the highest pulsatile blood 
pressure.  
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In an anatomical view, the aorta consists of the transverse 
aortic arch (AA) and straight thoracic and the abdominal 
descending aorta (DA), as shown in Figure 7. The major 
branches of the whole aorta include the innominate artery 
(first arterial branch in AA), renal arteries in the abdominal 
DA and the common iliac artery from the bifurcation of 
the DA.   
Figure 7. Anatomical view of a mouse aorta. Full-length 
mouse aorta was dissected under stereomicroscope and 
photographed by cell phone. The anatomical terms are labeled 
in the image. 
During the systole of the cardiac cycle, the blood is pumped out at the peak velocity. As the 
path starts to curve at an ascending aorta of AA, the blood going along the outer curvature 
tends to change direction towards the inner wall, resulting in a helical rotating of the flow. 
After passing the arch, the spiral flow turns into a laminar shear straight down to the DA. 
This dynamic flow pattern is repeated with each impulse of the heart. Understanding the 
hemodynamics of the aorta provides the fundamental basis for exploring EC biology in 
different parts of aorta.  
1.2.2.3 Mechanosensors at EC membrane 
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is an adhesion molecule located at 
the cell membrane that mediates homophilic contact with adjacent ECs. Early evidence has 
shown that fluid shear stress induces PECAM-1 phosphorylation, Shp2/ Gab1 recruitment 
and the activation of ERK (Osawa et al., 2002). Together with VE-cadherin and VEGFR2, 
PECAM-1 has been identified as a mechanosensing complex that mediates several shear 
stress responses, including EC alignment, NF-kB activation et cetera (Tzima et al., 2005).  
Integrins are capable of sensing minute changes in shear stress or cytoskeletal contractility, 
even though shear stress has no direct impact on the basal membrane (Guilluy, Dubash and 
Garcia-Mata, 2011). Integrin activation when subjected to shear induces integrin clustering, 
which is required for RhoGTPases and NF-kB activation. Integrins are an integral part of the 
response to mechanical force in ECs (Givens and Tzima, 2016). 
1.2.2.4 Arterial diseases 
Cardiovascular disease (CAD) remains the number one cause of mortality worldwide 
accounting for over 30% of all global deaths (data from https://ourworldindata.org/causes-
of-death). Arterial diseases, such as atherosclerosis and abdominal aortic aneurysm (AAA), 
are the most common but most life-threatening types, and they can be fatal due to the acute 
ischemia of vital organs or massive hemorrhage into the peritoneal cavity. 
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Atherosclerosis 
Atherosclerosis describes a chronic process leading to the narrowing and hardening of 
arteries due to the build-up of plaque. When the lumen is clogged, the consequence can be 
lethal depending on which arteries are affected. For instance, myocardial infarction is a 
serious consequence of coronary atherosclerosis.  
Aging and hypercholesterolemia are well known risk factors in atherosclerosis. Furthermore, 
atherosclerosis is linked to shear stress, as plaque formation generally occurs at sites with 
disturbed flow such as blood vessel bifurcations (Kwak et al., 2014; Cheng et al., 2006; Dai 
et al., 2004). Studies using unbiased systematic approaches (transcriptomics and proteomics) 
have revealed multiple pathways commonly regulated by altered shear stress conditions 
(Souilhol et al., 2019); these include bone morphogenetic protein (BMP) signaling 
(belonging to the TGFβ superfamily), hypoxia-inducible factor (HIF)-α, Notch, WNT, the 
homebox (HOX) family, the Hippo-YAP/TAZ pathway et cetera. For example, YAP is 
localized in the nucleus to a greater degree in areas exposed to disturbed rather than 
undisturbed flow in the mouse aorta (Wang et al., 2016a). In return, laminar flow inhibits 
YAP and TAZ activation (Wang et al., 2016c). 
Biochemical and biomechanical cues or damage to the endothelial layer may trigger the 
accumulation of circulating cytokines and, as a consequence, leukocyte extravasation as 
shown in Figure 8. Once monocytes transmigrate the endothelium, they begin to differentiate 
into macrophages, taking up oxidized low-density lipoproteins (oxLDL) and transforming 
into foam cells, which are the key component of atherosclerotic plague (Tajbakhsh et al., 
2018; Chistiakov et al., 2017). 
      
Figure 8. Progressive process of atherogenesis. The steps involved in the formation of 
atherosclerosis include: endothelium activation, leukocyte capture, rolling and adhesion, macrophage 
differentiation, and finally plaque development. Several selected cytokines and molecules are labeled 
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in the image, but it is not complete. Adapted from open-access article (Tsujikawa et al., 2019). 
Reprinted with permission from the publisher. 
Abdominal aortic aneurysm 
An AAA in humans is not a rare disease, presenting in up to 8% of the male population over 
the age of 65 and aneurysm rupture accounts for approximately 7,000 male deaths per year in 
the United States alone (Nordon et al., 2010). A sexual dimorphism has been reported by 
epidemiological reports in the development of AAA; that is, the prevalence of AAA in the 
population of males over 50 is 4–5 times greater than in women of the same age (Hannawa, 
Eliason and Upchurch, 2009; Katz, Stanley and Zelenock, 1997); however, women are no 
longer protected after post-menopause (Villard et al., 2011), suggesting that an endogenous 
sexual hormone underlines the sex differences in AAA (Boese et al., 2018). 
Ruptured AAA has an extremely high mortality rate (80%), and surgical repair with stents is 
currently the only available treatment (Golledge et al., 2019). The slow development of 
medical therapy for AAA is partially attributed to the lack of insights into its molecular 
mechanism, despite various mouse models for AAA studies (Lareyre et al., 2017; Angelov, 
Zhu and Dichek, 2017).  
Generally, there are three stages of AAA development: initiation, progression, and rupture, 
with different mechanisms implicated in human aortic aneurysm pathogenesis (Thompson et 
al., 2008). Table 2 provides a brief summary, showing that atherosclerosis and immune 
response are closely associated with AAA initiation and that vascular inflammation is 
therefore a high risk factor for aneurysm occurrence (Forester et al., 2005; Golledge et al., 
2006). Since 2006, the American Heart Association guidelines have suggested AAA as an 
atherosclerotic equivalent (Hirsch et al., 2006). What is also apparent is that biomechanical 
forces are potential drivers of every stage of aneurysm development. Excessive force caused, 
for example by hypertension, is a risk factor of AAA in both human and rodent studies 
(Golledge et al., 2006; Kanematsu et al., 2010). However, locally increased shear stress and 
wall tension can inhibit early aortic enlargement due to the reductions in oxidative stress 
(Nakahashi et al., 2002). Overall the forces need to be fine-tuned to maintain vascular 
homeostasis.  
 
Table 2. Mechanisms implicated in AAA initiation, progression and rupture. Summarized from 
(Golledge, Shi and Norman, 2011). Illustrated by Olof Andersson. 
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1.3 Angiomotin: A scaffold protein family 
The Angiomotins belong to a family of scaffold proteins that consists of three members 
Angiomotin (Amot), Angiomotin-like 1 (AmotL1) and Angiomotin-like 2 (AmotL2). These 
three members are characterized by a WW-binding motif Coiled-coil (C-C) domain and a 
PDZ-binding motif. Amot, but not AmotL1 or AmotL2, contains an angiostatin-binding 
domain between C-C domains and the PDZ binding motif. Each Amot consists of one full-
length isoform and a shorter variant, including p130/p80 Amot, p100/p90 AmotL1 and 
p100/p60 AmotL2 (Bratt et al., 2002; Nishimura et al., 2002).  
1.3.1 A brief history of the discovery of Amot proteins 
Amot (p80) was identified in 2001 as a membrane associated protein-binding angiostatin, 
which is the endogenous angiogenesis inhibitor circulating in the blood (Troyanovsky et al., 
2001). In 2006, the longer isoform of p130 Amot was reported in different cell types, 
including vascular ECs, whose N-terminal extension mediated the association with actin 
filaments. The transfection of p130 Amot induced the F-actin formation and the cell’s 
elongation in shape (Ernkvist et al., 2006). AmotL1 (p100) was identified from TJ protein 
screening using a fluorescence localization-based expression cloning method and is thus, also 
known as TJ-enriched and associated protein (Nishimura et al., 2002). Another short isoform 
of p90 AmotL1 was articulated to regulate EC polarity and junctional stability during blood 
vessel formation (Zheng et al., 2009). So far, no functional differences between p100 and p90 
isoforms have been reported. The last member, AmotL2 (p100, also known as LCCP or 
MASCOT), was discovered via homology searches and the assembly of data from GenBank 
and was included in the Amot family. Over several decades, numerous studies have 
uncovered the binding partners with those characterized domains, as summarized in the 
Figure 9. 
1.3.2 Amot proteins in vascular development 
Given that Amots were originally discovered as regulators of EC migration, a number of 
studies have focused on the role of Amot proteins in vascular development. Amot was 
initially discovered to mediate the angiostatin inhibition of EC migration and tube formation 
in vitro (Bratt et al., 2002; Levchenko et al., 2003). During mouse embryogenesis, most 
Amot knockout embryos (of 129/SvEv mouse strain) died soon after gastrulation with 
abnormal furrows of visceral endoderm as a result of the restraint of cell migration (Shimono 
and Behringer, 2003). In mice mixed between 129/SvEv and C57/B6, 75% of amot-null mice 
died between E11 and E15 due to severely insufficient vasculature in the intersomitic vessels 
and highly dilated brain vasculature (Aase et al., 2007). Furthermore, Amot knockdown 
endothelial tip cells in zebrafish became less migratory and exhibited a reduction in the 
number of filopodia, suggesting an anti-angiogenic effect (Aase et al., 2007). Antibodies 
targeting Amot using DNA vaccination and a human monoclonal antibody B06 have been 
generated as a result, and both have successfully inhibited tumor growth by blocking 
angiogenesis (Holmgren et al., 2006; Levchenko et al., 2008).  
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Since AmotL1 is 62–64% homologous to Amot, they were assumed to have certain 
overlapping functions. For example, an in vitro study showed that both AmotL1 and Amot 
promoted EC migration and influenced cell junction stability (Aase et al., 2007; Zheng et al., 
2009). However, they also displayed distinct functions in in vivo studies. Using a zebrafish 
model, our group verified that Amot controls EC migration during new blood vessel 
sprouting, whereas AmotL1 functions primarily to stabilize the cell–cell junction in stalk cells 
(Zheng et al., 2009).  
Similarly, the knockdown of AmotL2 in zebrafish resulted in impaired cell movement in 
mosaic embryos as a result of failed translocation of phosphorylated c-Src (Huang et al., 
2007). Later, AmotL2 has been demonstrated to link radial actin filaments to VE-cadherin 
junctional complex. These complexes transduce force through the cellular junctions and 
inactivation of amotl2 in mouse and zebrafish embryos abrogates aortic lumen expansion 
resulting in death in utero at embryonic day 10 (Hultin et al., 2014). A similar function of 
AmotL2 was uncovered in epithelial cells, in which AmotL2 connects to E-cadherin, 
organizes radial actin filaments, and is crucial for blastocyst hatching in pre-implantation 
mouse embryos (Hildebrand et al., 2017). In epithelium, hypoxia-induced p60 AmotL2 was 
identified in invasive tumor cells, promoting cell migration and metastasis (Mojallal et al., 
2014). However this isoform was not found expressed in vascular endothelium. 
1.3.3 Binding partners of Amot proteins 
 
 
Figure 9. Schematic of Angiomotin protein family. This scaffold protein family is composed of Amot, 
AmotL1 and AmotL2, each of which consists of two isoforms. The N-terminal conserved glutamine-
rich domains: LPTY binds cytoskeletal proteins MAG1-1 1 (Bratt et al., 2005; Hildebrand et al., 
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2017) and actin (Ernkvist et al., 2006); PPEY and PPQY are the sites for YAP and MST2 bindings 
(Mana-Capelli et al., 2014; Zhao et al., 2011); * depicts LATS1/2-dependent phosphorylation sites for 
of all Amots (Serine 176 for Amot for example) (Paramasivam et al., 2011; Chan et al., 2013); finally, 
the 220aa-307aa in AmotL2 p100 isoform has been identified to bind E-cadherin in epithelial cells 
and VE-cadherin in ECs. The C-C domain is associated with Merlin (Yi et al., 2011) and Rich1 (Wells 
et al., 2006). Amot (p130/p80) contains an angiostatin-binding domain (Bratt et al., 2005). The PDZ 
binding motif at the C-terminal binds to the apical polarity proteins Par3, Pals1 and Patj (Ernkvist et 
al., 2009; Wells et al., 2006). 
1.3.3.1 Hippo signaling pathway 
Classically, the Hippo pathway regulates cell proliferation, apoptosis and tissue formation, 
and it is intimately regulated by cell geometry. The signaling cascade includes MST and 
LATS-kinases, positively regulating the downstream transcriptional co-activators YAP and 
TAZ. Phosphorylated YAP is prevented from entering the nucleus, where it binds to the 
DNA-binding TEA domain (TEAD), to be transcriptionally active and drives the 
transcriptional programs that promote proliferation and inhibit apoptosis. Amot was first 
described as a YAP binding partner from a global proteomic data analyzing human 
deubiquitinating enzyme interaction (Sowa et al., 2009). Later, LPTY and the first PPEY 
motif from Amot and AmotL1, as well as the PPXY motif in AmotL2, were discovered to 
directly bind YAP (Moleirinho, Guerrant and Kissil, 2014). 
The direct binding of Amots/YAP has a high impact on YAP/TAZ subcellular localization. 
Overexpression of Amots in epithelial cell lines (HeLa and MCF7) induced YAP/TAZ 
retention in the cytoplasm (Wang, Huang and Chen, 2011; Zhao et al., 2011). However, the 
knockdown of Amot or AmotL2 in MDCK and MCF10A cells significantly increased the 
nuclear localization of YAP/TAZ, as well as the activation of YAP target genes evidenced by 
the up-regulation of CTGF and CYR61 (Zhao et al., 2011; Chan et al., 2013). In contrast to 
these findings supporting the negative regulation of YAP by the Amot family, p130 is 
required for YAP function, as described by Yi and colleagues in in vivo experiments, where 
liver-specific Amot knockout promoted tumorgenesis. The possible mechanisms might be 
that Amot inhibited YAP phosphorylation by competing binding domains to LATS1 in 
cytoplasm, as well as facilitating YAP within the nucleus to regulate downstream genes (Yi et 
al., 2013).  
The Hippo pathway can regulate the post-translational modification of Amot proteins, for 
example phosphorylation. Multiple experiments have confirmed the LATS1/2-dependent 
phosphorylation of Amot (serine 175), AmotL1 (s262), and AmotL2 (s159) at N-terminal 
WW binding domains (Hirate et al., 2013; Adler et al., 2013; Dai et al., 2013; Chan et al., 
2013). In the context of neurobiology, LATS1 has been recently indicated to be a neuronal 
regulator of p130 Amot by specifically phosphorylating the N-terminal sites of s175 during 
brain development (Wigerius et al., 2018). 
1.3.3.2 The associations with cell polarity, junctional and cytoskeletal proteins 
Several pieces of evidence have reported the importance of the C-terminal PDZ binding motif 
for Amots function in promoting EC migration. Knockdown only PDZ motifs in Amot and 
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AmotL2 was sufficient to limit EC migration in zebrafish embryos and the endothelial-
specific deletion of Amot PDZ binding domains led to embryonic death by E9.5 (Huang et 
al., 2007; Ernkvist et al., 2009; Levchenko et al., 2003). Through this PDZ binding motif, 
Amot, AmotL1, and AmotL2 are able to directly bind to PDZ-3, -1 and -2 domains of 
polarity protein Patj/Mupp1 respectively (Sugihara-Mizuno et al., 2007). Simultaneously, 
Patj/Mupp1 associates with a RhoA GEF binding protein Syx to mediate Syx transportation 
from cell junctions to the leading edge of migrating ECs. Thus Amots contribute to the 
recruitment of Syx for to localize RhoA activity (Ernkvist et al., 2009). In addition, another 
cell polarity protein Par3 binds to the PDZ domains of AmotL2 (Bratt et al., 2002; Mojallal et 
al., 2014). This binding enabled AmotL2 to localize to the cell junction together with VE-/E-
cadherin, which was essential for radial F-actin organization (Hultin et al., 2017). The 
physical association of AmotL2 to E-cadherin in epithelial cells and VE-cadherin in ECs was 
found to be highly dependent on the N-terminal PPxY motif (220-307a.a. and 101-307a.a., 
respectively) determined by Co-IP of different AmotL2 constructs (Hultin et al., 2017; 
Hildebrand et al., 2017). Furthermore, the shorter isoform p80 Amot has been identified as an 
interacting partner of mesenchymal junctional cadherin-Cdh11 (or osteoblast-cadherin) to 
promote epithelial cell migration (Ortiz et al., 2015). 
MAGI-1 is another crucial component that forms a complex with E-cadherin and α-catenin 
during cell junction formation in epithelial MDCK cells (Dobrosotskaya and James, 2000; 
Hildebrand et al., 2017). Additionally, MAG1-1 influences actin cytoskeleton dynamics by 
being physically bound to the actin bundling proteins synaptopodin and α-actinin-4. 
Interestingly, AmotL2 was once given the name MAGI-1-associated coiled-coil tight junction 
protein, since it was identified from a glomerular cDNA library screening for MAG1-1 
binding partners (Patrie, 2005). In the same year, another independent experiment confirmed 
the association between p130 Amot and MAGI-1b in CHO cells (Bratt et al., 2005). In 
addition to stabilize junctional proteins, the N-terminal domain of p130 Amot transfection in 
MAE cells induced actin fiber formation that affected EC shape and motility (Ernkvist et al., 
2006), suggesting that Amot proteins might organize actin filaments and connect them to the 
cell junctions. 
Epithelial or endothelial sheet/tube formations are the initial and fundamental processes of 
multicellular tissue construction and organogenesis, which requires the precise integration 
and regulation of multiple cellular events, such as apical-basal membrane polarity, 
intercellular junction and the organization and control of cell geometry by the cytoskeleton. 
Amot proteins are of interest because they localize membrane receptors with polarity protein 
complexes and the cytoskeleton, as well as regulate the Hippo pathway. Therefore these 
scaffolds integrate essential morphogenetic cues to control cell shape, cell polarity and the 
proliferation of multicellular tissues.  
Taken together, those findings indicate that Amot proteins are able to integrate various 
structural proteins to influence cell morphology and function in vascular biology.  
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2 AIMS OF THIS THESIS 
All three members of this family—Amot, AmotL1, and AmotL2—are scaffold proteins; they 
associate membrane receptors with polarity proteins and the cellular cytoskeleton. In this 
thesis, we have examined genetic mouse models to understand how these protein complexes 
are involved in vascular development, homeostasis and disease. We propose that the main 
role of the Amot family is to transmit mechanical cues from the environment to the cellular 
cytoskeleton.  
To this end, my colleagues and I, have addressed the following specific aims: 
 
Paper I 
To study the role of Amot in transmitting mechanical force in migrating ECs.  
 
Paper II 
To experimentally test the “integrin switch” theory and develop a probe that can specifically 
detect strained Fn upon enhanced micro-environmental mechanics. 
 
Paper III 
To investigate the function of AmotL1 in vascular remodeling during angiogenesis and the 




To investigate the role of the VE-cadherin/AmotL2 mechanotransductory complex in 
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3 METHODS AND MATERIALS 
3.1 Mouse models 
Animal models that can truly recapitulate developmental and pathological processes are 
extremely important in translational research and drug development. Among a number of 
organisms studied, mice have stood out as the most widely used model, despite differences in 
metabolic rate, diets, microbiomes and other aspects (Perlman, 2016). The irreplaceable 
advantages of mice models include high genetic homologies (85% on average) with humans, 
ease of genetic manipulation, relatively cheap maintenance, time-efficiency for high 
throughput studies et cetera (Vandamme, 2014; Waterston et al., 2002; Rosenthal and Brown, 
2007). 
In this thesis, we have employed several mouse models and we are committed to the 
principles of the 3Rs (replacement, reduction and refinement) in experiment design. Ethical 
permits for Papers I, III and IV were obtained from the North Stockholm Animal Ethical 
Committee and the ethical permit for Paper II was granted by the Georgia Tech Institutional 
Animal Care and Use Committee (IACUC). 
3.1.1 Conditional knockout mouse models (Papers I, III, and IV) 
According to our aims to delineate the function of Amot proteins in vasculature in vivo, we 
established three endothelium-specific knockout mouse strain in the background of C57BL/6J 
based on a Cre-Lox recombination system (Sauer, 1987) (Monvoisin et al., 2006).  
3.1.1.1 amotflox-Cdh5(PAC)CreERT2-ROSA26-EYFP mice (amotec- mice) 
Amot, as the target gene, was flanked by two loxP sites for Cre-recombinase to bind. 
Specificity of the endothelium deletion was accomplished by control of Cre expression under 
Cdh5(PAC)(VE-cadherin) promoter. To gain control of Cre activity, sequences from the Cre 
gene as well as sequences encoding a mutant form-ERT2 of estrogen receptor binding domain 
were fused (Danielian et al., 1993; Metzger and Chambon, 2001; Feil et al., 1997; Leone et 
al., 2003). Once tamoxifen is injected, the Cre protein gains freedom by dislocating from the 
fusion protein, in order to enter nucleus and initiate “prune” activity. In addition, to evaluate 
the activation of Cre-recombinase, we introduced the ROSA26-EYFP (enhanced YFP) 
reporter into amotflox-Cdh5(PAC)CreERT2 mice. When Cre-recombinase targets the loxP sites 
YFP is expressed, which allows the efficacy of Cre-recombination on individual cells to be 
monitored by YFP immunostaining (Srinivas et al., 2001). 
Amotec+ and amotec- are the abbreviations to refer to amotwt-Cdh5(PAC)CreERT2-ROSA26-
EYFP and amotflox-Cdh5(PAC)CreERT2-ROSA26-EYFP mice, respectively. It is worthy to note 
that amot gene is located in the X chromosome, and we therefore use amotec+ and amotec- for 
female mice to avoid confusion. 
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3.1.1.2 amotl1flox/flox-Cdh5(PAC)CreERT2-ROSA26-EYFP mice (amotl1ec-/ec- mice) 
In the same fashion, we established a mouse model for the AmotL1 endothelium-specific KO 
mouse model. Amotl1ec+/ec+ and amotl1ec-/ec- are the abbreviations for amotl1wt/wt-
Cdh5(PAC)CreERT2-ROSA26-EYFP and amotl1flox/flox-Cdh5(PAC)CreERT2-ROSA26-EYFP 
mice, respectively. 
3.1.1.3 amotl2flox/flox-Cdh5(PAC)CreERT2-ROSA26-EYFP mice (amotl2ec-/ec- mice) 
Amotl2ec+/ec+ and amotl2ec-/ec- are the abbreviations for amotl2wt/wt-Cdh5(PAC)CreERT2-
ROSA26-EYFP and amotl2flox/flox-Cdh5(PAC)CreERT2-ROSA26-EYFP mice, respectively. 
3.1.2 Mouse model of retinal angiogenesis (Papers I and III) 
The mouse retina permits the study of angiogenesis in a natural context in vivo with several 
advantages that the other in vitro and in vivo models lack (Stahl et al., 2010; Uemura et al., 
2006).  
• Hierachical vascular networks forming only after birth allow us to observe diverse 
processes, including angiogenesis (tip cells sprouting), capilliary maturation, artery 
and vein differentiation et cetera.  
• Laminar superfical blood vessel patterning is reproducible and accessible for 
monitoring and analysis. 
• Mural cell, astrocyte and other cell types involved in angiognesis are well 
characterized. 
As opposed to human babies, the retinas of new born mouse pups are avascular (Gyllensten 
and Hellstrom, 1954). Vessels start to expand from the central optic nerve immediately after 
birth and reach the periphery of the retina at P8. During the expansion of the vascular 
network migrating EC tightly followed the guidance of network of astrocytes (Dorrell, 
Aguilar and Friedlander, 2002). Proceeding the ECs, astrocyte begins to emerge from the 
optic nerve around E19 (embryonic day 19), and ECs therefore migrate on the pre-paved 
astrocytic template after birth (Dorrell and Friedlander, 2006). The developing retinal 
superficial vasculature is illustrated at characteristic time points postnatal day 2 (P2), P4 and 
P6 in Figure 10. 
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Figure 10. Schematic of postnatal vascular development in mouse retina. During the first week, the 
superficial vascular plexus extends radially from the optic nerve. The time course of blood vessel 
growth in postnatal retinas was exemplified at P2, P4 and P6. The non-remodeled vascular plexus is 
shown in red, arteries in red, veins in blue and the Fn-expressing astrocyte network in green. Adapted 
from (Tata, Ruhrberg and Fantin, 2015). Reprinted with permission from the publisher. 
 
To induce Amot recombination and ablation, mice were treated with tamoxifen (400 
µg/mouse/day) by intraperitoneal injections from P1 to P3. Normally, the Cre-recombinase 
efficiency was above 90%, tested by YFP immunostaining in our system. A lower dosage 
was also applied with the intention of decreasing recombination frequency to facilitate 
competitive studies of amotec+ and amotec- cells for tip cell positioning. Retinas were harvested 
at P6 for retinal angiogenesis and subsequently analyzed according to the protocol by 
Pitulescu and colleagues (Pitulescu et al., 2010). To ablate Amot in adult mice, tamoxifen (2 
mg/mouse/day) was administrated for five days in a row, and the retinas was harvested seven 
days later. 
3.1.3 Tumor transplantation mouse model (Papers I and III) 
We studied tumor angiogenesis using the tumor with Lewis Lung Carcinoma (LLC) 
transplantation model. The LLC cells were originally derived from a C57BL/6 mouse and 
were thus syngeneic with our genetic mouse models. The LLC model has been extensively 
used for tumor angiogenesis studies due to its rapid growth with hyperneovascularization 
induced by pro-angiogenic factors released form the tumor cells. 
Mice at six weeks of age were injected by tamoxifen to activate gene ablation. LLC cells 
(0.5×106/mouse) were injected subcutaneously on the last day of tamoxifen injection. Tumor 
growth was manually inspected twice per week, and tumor volumes were calculated. Starting 
from two weeks after the first injection, the same dosage of tamoxifen was injected into the 
tumor-bearing mice for five days. When tumors reached 10 mm in diameter, the mice were 
sacrificed according to the ethical permit. 
3.1.4 MMTV-PyMT transgenic mouse model (Papers I and III) 
The MMTV-PyMT transgenic mouse model is widely used to study mammary tumor 
progression and metastasis. In the MMTV-PyMT model, mammary gland–specific 
expression of the PyMT (polyoma middle-T) oncogene driven by the upstream mouse 
mammary tumor virus (MMTV) results in the rapid development of multifocal mammary 
adenocarcinoma occurring at around the age of 8–9 weeks (Lin et al., 2003).  
We crossed our conditional knockout mice (amotec- and amotl1ec-/ec-) mice into the MMTV-
PyMT background and induced gene endothelial specific depletion at week four by a 
tamoxifen injection five days (2 mg/mouse/day) prior to the occurrence of breast tumors. 
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3.1.5 Mouse bleomycin model of pulmonary fibrosis (Paper II) 
Idiopathic pulmonary fibrosis is a chronic disease that leads to death, and the bleomycin 
animal model is one of the best mouse models available to study the pathogenesis and test a 
potential drug (Mouratis and Aidinis, 2011). In addition, this model has been characterized by 
high reproducibility and a variety of administration routes. Bleomycin can induce DNA 
breaks that lead to lung injury and fibrosis (William Lown and Sim, 1977) and acute lung 
injury can be observed after seven days followed by a 3-4 week fibrotic stage, and then the 
pathological situation can return to normal with minimal fibrosis (Chung et al., 2003). 
Female mice at six weeks of age were anesthetized using a ketamine/xylazine/acepromazine 
cocktail, and injected with bleomycin sulfate at a dose of 2 U/kg (50 µL with 10 µL of air 
bolus) through intratracheal injections. Mice were placed on a warm pad until they recovered 
and lung tissues were harvested  
3.1.6 Mouse model of aortic function (Papers I and III) 
An AAA is a focal dilation of the aorta and may rupture, resulting in extensive bleeding into 
the abdominal cavity. The prevalence of AAA increases with age in humans. To mimic the 
human condition as closely as possible, our studies recruit mice (both males and females) 
aged between 6 and 8 months (the alleged lifespan of our mouse strain is 1.5 years). Four 
weeks after we induce gene knockout by five days of standard tamoxifen injections, we 
harvest the aorta, vena cava, bladder and other organs for analysis. The dissection and 
perfusion protocol follows (Robbins et al., 2014).  
Despite the primary advantages of the mouse model in our study on vascular inflammation, 
including the low cost, ease of breeding and genetic manipulation and rapid development of 
atherosclerosis, some characterized vascular events cannot be fully recapitulated in the mice 
(Getz and Reardon, 2012). For instance, the sites of atherosclerosis in mice usually occur in 
the aortic arch and innominate artery, rather than the carotids and coronary arteries in 
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3.2 Human materials 
To corroborate the data from our mouse models presented above, we also analyzed human 
patient materials, primarily using immunohistochemical (IHC) stainings and RNA expression 
analysis.  
3.2.1 Human Protein Atlas (Paper I) 
The Human Protein Atlas is a Swedish-based program initiated in 2003 and aiming to map all 
the human proteins in cell, tissue, and organs (http://www.proteinatlas.org). Various omics 
technologies have been included for the exploration of the human proteomes, for example, 
imnnunostaining imaging and mass spectrometry-based proteomics (Uhlen et al., 2015).  
3.2.2 Human aortic aneurysm samples (Paper IV) 
Human AAA samples were obtained from vascular surgeries in Karolinska Hospital, Media 
and adventitia parts of the AAA samples without any thrombosis attachment were analyzed 
by GeneChip™ Human Transcriptome Array 2.0. 
Proper ethic permits were granted by Regionala etikprövningsnämnden i Stockholm. 
3.2.3 Human primary cell line (Paper IV) 
For studies of AmotL2’s function in aortic and venous endothelium in vitro, we purchased 
primary cell lines of the Human Aortic Endothelial Cell (HAoEC) and Human Umbilical 
Vein Endothelial Cell (HUVEC), respectively. As stated previously, the incidence of AAA is 
higher in males over middle age. Therefore the HAoEC cell batch we used in Paper IV was 
from a Caucasian male donor at age 55. 
To maintain the proper characters of primary cells, we performed experiments only on those 
cells at low passages (less than five) and cultured the cells under standard guidelines 
(Geraghty et al., 2014).  
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4 RESULTS AND DISCUSSION 
4.1 The Amot/integrin protein complex transmits mechanical forces required 
for vascular expansion. (Paper I) 
4.1.1 Amot is primarily expressed in developing blood vessels. 
Amot has been reported to express preferentially during physiological angiogenesis of 
zebrafish and mouse (Aase et al., 2007). However, other publications have indicated Amot as 
a regulator of the Hippo pathway in epithelium in vitro to affect tumor progression (Lv et al., 
2017). To clarify the discrepancy, we mapped the expression pattern of Amot in normal and 
cancerous human tissues using immunoaffinity-purified Amot antibodies with high 
specificity (Levchenko et al., 2003). Amot positivity was restricted to angiogenic sites, such 
as blood vessels of the third-trimester placenta. Furthermore, Amot was barely detectable in 
areas outside the blood vessels in adult tissue such as brain and breast. Consistently, up-
regulation of Amot in tumor vessels and stroma was observed in human cancers of different 
origins, whereas the surrounding tumor cells were negative. We therefore have concluded 
that Amot primarily functions in angiogenic blood vessels during tissue remodeling after 
birth. 
4.1.2 Amot is required for both retinal and tumor angiogenesis. 
Using our endothelium-specific knockout mice, we inactivated amot in ECs by tamoxifen 
injections during the first three postnatal days. A significant non-symmetrical and partially 
collapsed vessel expansion could be observed in amotec- retina of P6 (Figure 11). Confocal 
microscopy analysis revealed a significant decrease in the number of tip cells, as well as 
reduction in filopodial extensions. Interestingly, no blood vessel aberrations were detected 





Figure 11. Poor expansion of blood 
vessel network in amotec-. mouse retina. 
The blood vessel network was 
visualized by IB4 staining.
To investigate whether the impaired vascular expansion is caused by a defect in tip cell 
migration rather than capillary development, we decreased the doses of tamoxifen injection, 
resulting in lower recombination frequencies (YFP positivity). When the recombination 
frequencies are lower than 85%, amotec- EC showed a decreased ability to localize in tip cell 
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positions but no obvious ratio change in capillaries, which indicated its disadvantages in 
leading the migrational front.  
As we could detect the up-regulation of Amot in blood vessels of human tumors, we further 
investigated whether Amot also played a role in tumor angiogenesis. Here we employed two 
tumor models for pathological angiogenesis: Lewis Lung Carcinoma (LLC) transplantation 
and the transgenic mouse model of breast cancer MMTV-PyMT. First, LLC tumors growing 
in an Amot EC–free environment were significantly smaller as assessed by tumor weight, 
than amotec+ mice. Immunostaining sections from resected tumors showed a marked decrease 
in vascular density and an increased percentage of necrosis. In the second transgenic breast 
tumor model, we induced amot endothelial specific depletion at week four. Normally, 
multiple breast tumors occur at around 8–9 weeks of age in amotec+ mice; however, an 
analysis of early onset tumor occurrence displayed an average of six weeks longer latency in 
amotec- mice, confirming the protective effect of amot deletion on tumor incidence by 
inhibiting angiogenesis.  
Our previously studies have reported a DNA vaccination against Amot, which blocked 
angiogenesis, thereby preventing growth of a transplanted tumor in vivo (Holmgren et al., 
2006). In addition, an Amot antibody (Bo6-scFv specific for human and mouse p80 Amot) 
has been testified for its anti-angiogenic effect in mice (Levchenko et al., 2008). In 
conclusion, we propose that Amot is a potential therapeutic target to inhibit both physio- and 
pathological angiogenesis. However, to make the targeting antibody suitable for long-term 
treatment in vivo, more work must be done to prolong the half-life in circulation. 
4.1.3 Amot relays force between EC and ECM in vivo and in vitro. 
Early work by Ingber and Folkman showed that mechanical interactions between ECs and 
ECM regulated capillary development in vitro (Ingber and Folkman, 1989). This led to 
research that showed that ECM properties, such as matrix stiffness, controlled cell shape and 
function by modulating the cytoskeletal network (Ingber et al., 1995). A hypothesis was 
proposed that the lack of contractile force between endothelial tip cell and ECM causes, at 
least partially, the collapsed vasculature in the absence of Amot. Here we provide three 
approaches to show that Amot is essential for the transmission of force between the Fn 
component of ECM and the cytoskeleton of migrating ECs.  
1. EC-specific knockour of Amot led to changes in Fn fibrillogenesis in vivo as analysed 
by enhanced resolution confocal microscopy. That is, Fn fibrils were stretched and 
aligned with tip cell filopodia in amotec+retina, whereas Fn was localized to punctate 
and shorten fibrils in amotec-, implying less local extension. 
2. We exploited H5-scFv targeting a conformation change of Fn when exposed to 
mechanical strain, thus unmasking a cryptic epitope (more details in Paper II). Amot 
deficient cells had a lower ratio of strained vs pan-Fn in the adjacent matrix.  
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3. Direct measurements of force using TFM on an Fn-coated matrix in vitro supported 
the notion as well. Amot siRNA–depleted cells exhibited a significant decrease in the 
force exerted on the Fn-coated polyacrylamide gel. 
4.1.4 Amot is a novel component of the integrin adhesome. 
To investigate the molecular mechanisms involved in the Amot-mediated force transmission, 
we performed RNA sequencing analysis (RNA-seq) of control and Amot KD cells and Mass 
Spectrometry (MS) analysis of Amot-associated proteins in BAE cells. To focus on the cell-
matrix interaction, the cells used for in vitro study were cultured at 40% confluent. The omics 
analyses unveiled an enrichment of genes that positively regulate the “focal adhesion” and 
“ECM-receptor interaction” KEGG pathways, and several integrin subtypes were recognized 
from the protein list, including β3, α5, and β1. We verified these data by immunoprecipitation 
analysis using either Amot- or integrin-specific antibodies. Interestingly, Amot siRNA 
depletion resulted in less actin associated with primarily the αvβ3-integrins. Consistently, a 
recent study reported that endothelial tip cell migration during angiogenesis involves 
mechanical force to unfold Fn with αvβ3-integrin binding sites in ECM (Li et al., 2017).  
To further identify the subcellular localization of Amot, we performed an in situ proximity 
ligation assay (PLA) to analyze the co-localization of Amot with the focal adhesion protein 
vinculin. The PLA positive dots overlapping with actin filaments indicated a close proximity 
(proteins within 40 nm) of Amot and vinculin in MS1 cells. Importantly, this signal was 
essentially abrogated by Amot siRNA depletion, but could be rescued by re-expression of 
Amot using a mouse p130-Amot-GFP plasmid transfection. The same results were obtained 
from HEK 293 cells, a cell line that we earlier reported expressed high levels of p130 Amot. 
In all, our data show that Amot is a novel component of the integrin adhesome in ECs. 
The integrin adhesome has been extensively studied and over 200 proteins have been 
implicated in the cell-ECM interaction (Horton and Humphries, 2016). In 1994, αvβ3 became 
the first integrin proposed to be high expressed in angiogenic ECs (Brooks et al., 1994). 
Since then, extensive studies has focused on inhibiting αvβ3 to suppress tumor angiogenesis 
without affecting quiescent ECs. Genetic deletion before a tumor challenge transiently 
suppressed tumor angiogenesis; however, the effect on growing tumors was minimal (Steri et 
al., 2014). Certainly, there are more subtypes of integrins and multiple tension-sensitive 
binding partners involved in blood vessel growth in tumors. Further insight on how 
mechanical force transduced may shed light on better strategies to target those pathways. 
The role of Amot appears to be the formation of actin filaments. Previous work has shown 
that Amot binds and promotes F-actin formation, which regulates the activity of the YAP 
transcription factor (Ernkvist et al., 2006; Mana-Capelli et al., 2014). The interaction with the 
cytoskeleton is at least partially mediated by the Rho-GEF protein PLEKHG1/Syx, which 
binds Amot and promotes EC migration by governing RhoA GTPase activity (Ernkvist et al., 
2009; Garnaas et al., 2008).  
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Taken together, we proposed a mechanism of endothelial tip cell migration on ECM enabled 
by mechanical force transition unit-Amot/Integrin-associated adhesive protein complex in 
charge of relaying force between ECs and the ECM (Figure 12).     
      
Figure 12. Amot as a component of an integrin-associated adhesion complex. Full aortae of 
amotl2ec+/ec+ and amotl2ec-/ec- were anatomically isolated and presented in the left image. A wild-type 
piece of aorta was framed in the orange box and AAA in the blue box. The images with whole-mount 
staining of TOPRO (blue), F-actin (red) and VE-cadherin (green) were shown on the right. 
 
4.2 Detection of an Integrin-binding mechanoswitch within fibronectin during 
tissue formation and fibrosis. (Paper II) 
4.2.1 Fn strain drives differential integrin affinity. 
Krammer and his team have forwarded the theory of a “switch” of the integrin binding profile 
of Fn triggered by mechanical forces (Krammer et al., 2002). To verify this theory with 
experimental evidence, we used two pre-engineered Fn fragments spanning the ninth and 10th 
type III repeats of Fn to test whether integrins have preferential affinity (Brown et al., 2015; 
Martino et al., 2009). Simply speaking, FnIII9*10 is the native and stabilized fragment, 
whereas FnIII9-4G-10 has an approximate 0.9 nm separation between the PHSRN and RGG 
sites, therefore representing a strained conformation of the Fn fragment. By SPR experiments 
and the IF staining of integrins on cells culture on those Fn fragments, we are the first to 
show that α5β1-integrin prefers to bind the native FnIII9*10, and the affinity were decreased 
on the mechanically perturbed FnIII9-4G-10 fragments. This switch was not observed on 
αvβ3-integrin, since αvβ3 has similar binding affinity to FnIII9-4G-10 as well. A similar high 
affinity of α5β1-integrin engagement on strained Fn has been articulated earlier, using a 
designed Fn-mimetic peptide (Craig et al., 2008). These observations together lead us to 
develop a promising probe to further confirm the switch theory. 
4.2.2 H5 scFv was developed to detect conformation change of strained Fn. 
To generate a probe targeting the force-sensitive conformational change in the integrin-
binding domain of Fn, we used FnIII9*10- and FnIII9-4G-10-predicted Fn fragments as 
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template models. In addition to the extended distance between PHSRN and RGD due to the 
4G insert in FnIII9-4G-10, the stability also differs in the flexible 4G regions. This flexibility 
is of importance to recapitulate the sensitivity of FnIII repeats to force-induced unfolding 
(Krammer et al., 2002; Li et al., 2005). By performing phage display panning and selection 
based on scFv antibody libraries on those Fn fragments (de Wildt et al., 2000; Lee et al., 
2007), Clone H5 stood out among the 40 clones as displaying a high affinity against the 
extended FnIII9-4G-10, but not to the stabilized conformation of FnIII9*10.  
To validate H5’s recognition of FnIII9, we manually deposited an Fn fiber pre-patterned and 
stretched PDMS (polydimethylsiloxane) membrane. With the increase of strain manipulated 
by the system, H5 binding displayed a switch-like behavior: The H5 signal sharply increased 
at the extension ratio of 1.4–1.5 and plateaued with further stretching (Figure 13). Similarly, 
on another independent system of elastic PDMS membrane assembling decellularized Fn-rich 
ECM, H5 staining was able to specifically recognize strained Fn over relaxed Fn ECMs, both 
globally and locally. The intensity of H5 staining was strongly regulated by the contractile 




Figure 13. H5 scFv is capable of targeting 
conformational change in Fn’s integrin-binding 
domain. The transition of the “switch” from low to high 
binding affinity occurs at the extension ratio of 1.25–1.5.
4.2.3 H5 probe highlights strained tissues in ex vivo models.  
In addition to validating H5 in vitro, we tested H5 in two well-established mouse model 
systems: pulmonary fibrosis and postnatal retinal angiogenesis (described in Methods and 
Materials). Bleomycin treatment induced severe fibrosis two weeks after administration. 
Three to four weeks later, fibrosis began to resolve and almost returned to a normal state at 
week 10. Radiometric images analysis of H5/pan-Fn staining exposed a positive correlation 
between H5 intensity and the severity of fibrosis, which suggested that H5 is able to 
distinguish the conformational states of Fn within the native tissue. 
In another mouse retinal angiogenesis model, the vascular network starts to expand at birth 
(Pitulescu et al., 2010). The migrational endothelial tip cells are guided by an Fn template 
pre-deposited by astrocytes (Jiang et al., 1994). H5/pan-Fn ratios were significantly higher in 
areas where the filopodia of tip cells interact with elongated Fn fibrils, compared to 
established mature capillaries. These combined results proposed a mechanism whereby forces 
that are generated from endothelial tip cells unfold Fn to expose αvβ3-binding sites within the 
ECM influencing angiogenesis. Interestingly, Paper I verifies that Amot relays forces 
between tip cells and Fn fibrils through integrin-associated adhesome. αvβ3-integrin shows 
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more dependency on Amot than α5β1-integrin with respect, regarding to connecting the 
cytoskeleton to exert a contractile force. This finding is further supported by research 
conducted by (Li et al., 2017), which emphasizes that α3/α5β1- and αvβ3- integrin 
stimulation may be harnessed to have the opposite influence during reparative angiogenesis. 
Overall, the data suggested a potential integrin binding specificity in developing tissues. 
Finally, we have provided an experimental demonstration of switched integrin binding to Fn 
with force-sensitive conformational changes. Furthermore, an H5 probe shows a convincing 
ability to detect a stretched conformation of Fn in native tissues, which increases the 
possibility of using H5 as a paradigm for the imaging and diagnosis of fibrotic tissues. 
 
4.3 AmotL1 is a novel component of the N-cadherin complex affecting 
endothelial/pericyte interaction in normal and tumor angiogenesis. 
(Paper III) 
4.3.1 AmotL1 deficiency affects vessel formation in mouse retina and tumor. 
The aim of this paper was to study the role of AmotL1 in vascular development. To this end, 
we analyzed the effects of amotl1 inactivation during postnatal vessel expansion in mouse 
retina using EC-specific KO models as previously described in Paper I. The phenotype 
differed significantly from that of the amot ablated retina. The amotl1ec-/ec- vascular network 
exhibited a significant reduction in vascular density and a decreased amount of branching in 
the periphery as well as in the central retina. Besides the ECs, other cell types also contribute 
to the forming function of the circulatory network. Microglial cells and astrocytes did not 
show any obvious macroscopic differences in appearance. However the whole-mount 
immunostaining showed that the area of pericyte coverage decreased and the cells “bulged 
out” from the retinal vessels (depicted in Figure 14). 
 
                          amotl1ec+/ec+                                                                                amotl1ec-/ec- 
                            
Figure 14. Schematic illustrating poor pericyte coverage in an amotl1ec-/ec- vessel. Pericyte bulges 
out with AmotL1 absence in the endothelium as a non-autonomous effect.   
In addition to physiological vascular development, we assessed the role of AmotL1 in the 
vasculature of the LLC transplantation and MMTV-PyMT mouse tumor models, as described 
previously. Tumors growing in the absence of AmotL1 in endothelium had a significant 
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increase in vessel diameter. A prolonged period of tumor latency in amotl1ec-/ec- mice was 
suggested to be attributed to the lower functionality of tumor blood vessels. 
Extensive studies have shown that endothelial-derived platelet-derived growth factor subunit 
B (PDGFB) is crucial for pericyte recruitment in newly formed vessels (Armulik, Genove 
and Betsholtz, 2011). Genetic ablation of PDGFB changes the retinal vascular density and 
enlarges the tumor blood vessel diameter (Abramsson, Lindblom and Betsholtz, 2003), a 
finding quite similar to our discoveries during normal and tumor blood vessel development.  
How does AmotL1 KO in endothelium cause vessel dilation and generate a defect of 
contacting pericyte coverage in a non- autonomous fashion? 
4.3.2 AmotL1 belongs to N-cadherin associated adhesive junction between 
EC and pericyte. 
ECs and pericytes are tightly connected in functional mature blood vessels. The two distinct 
cell types communicate by paracrine biochemical factors as well as direct physical contact in 
cell–cell adhesions mediated by N-cadherin (Gerhardt, Wolburg and Redies, 2000). 
Endothelial cells also express N-cadherin that is, in contrast to VE-cadherin, not endothelial 
specific, as it is expressed in multiple-types of mesenchymal cells, such as pericytes 
(Cavallaro, Liebner and Dejana, 2006). Therefore N-cadherin is a possible binding partner for 
AmotL1. However, no binding evidence could be detected between AmotL1 and N-cadherin 
by Co-IP analysis. Previous reports have suggested that N-cadherin junctional localization is 
governed by VE-cadherin expression (Navarro, Ruco and Dejana, 1998; Hordijk et al., 1999; 
Giampietro et al., 2012), and in vitro, N-cadherin has a dispersed distribution on the cellular 
membrane, however it changed location to adherent junctions in VE-cadherin depleted cells 
(Salomon et al., 1992). As expected, using cells either treated by VE-cadherin siRNA to 
knock down AmotL1, and purified from VE-cadherinec-/ec-mice, AmotL1 was detectable from 
N-cadherin immunoprecipitate, but not Amot or AmotL2. This is the first time that AmotL1 
was shown to be a part of the N-cadherin adhesion complex when N-cadherin is recruited to 
cell junctions  
N-cadherin is commonly expressed in mesenchymal cells including vascular mural cells, such 
as SMC (smooth muscle cell). Ji-Hye Paik and colleagues have reported that blocking N-
cadherin binding in in vitro co-cultures abrogated the interaction of ECs and pericytes (Paik 
et al., 2004). The results are also supported by in vivo data that N-cadherin is required for the 
blood vessel stabilization by regulating the interaction of ECs and pericytes (Gerhardt, 
Wolburg and Redies, 2000). Furthermore, the genetic inactivation of N-cadherin resulted in 
impaired pericyte coverage of endothelial sprouts in vitro (Tillet et al., 2005), similar to our 
findings with AmotL1 KO.  
These data raised an interesting question: The EMT (epithelial-mesenchymal transition) 
involves the down-regulation of E-cadherin and the up-regulation of N-cadherin, which 
assists the adhesion to ECs and thus extravasation and metastasis (Wells et al., 2011). This 
leads to the question of whether AmotL1 is involved in tumor cell migration and spreading as 
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well. A recent study has shown that AmotL1 is up-regulated and promotes invasion in breast 
cancer (Couderc et al., 2016). Moreover, protein analysis on tumor samples from MMTV-
PyMT mice has manifested a high level of AmotL1 expression. Further studies may shed 
light on whether the tumor–endothelial interactions are dependent on mechanical forces 
relayed by AmotL1. 
In summary, AmotL1 is identified as a specific partner of N-cadherin in both ECs and 
pericytes and the tensional balance maintained by and proper endothelial/pericytes interaction 
is important for vascular network organization. 
 
4.4 The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic 
inflammation and the formation of abdominal aortic aneurysms. (Paper 
IV) 
4.4.1 AmotL2 is essential for aortic morphology in response to flow. 
Previous data has shown that AmotL2 is essential for aortic lumen expansion during 
embryonic development in both mouse and zebrafish models (Hultin et al., 2014). To explore 
AmotL2 functions in the aorta of adult mice, we first mapped the AmotL2 expression pattern 
in the largest vessels: the descending aorta (DA) and the inferior vena cava (IVC). The 
immunostaining with AmotL2 revealed that AmoL2 was primarily expressed in the aortic 
endothelium rather than the IVC. This preference was also observed in major retinal arterials 
in adult mice.  
The ECs of the DA tended to be aligned with the direction of blood circulation and 
contained radial actin filaments that were connected to the cellular junctions. By contrast, 
the ECs of the IVC exhibited a more rounded cellular shape with no or few detectable 
radial actin filaments. Using an inducible AmotL2 knockout mouse model to abrogate 
AmotL2 in adult mice, we observed a loss of radial actin filaments and a rounder cell shape 
in the ECs of DA one month after AmotL2 inactivation. However, a similar change was not 
detected in IVC endothelium. This artery-specific phenotype was also observed in the 
arterial ECs of other organs, such as the urinary bladder. This phenomenon could also be 
recapitulated in in vitro flow experiments. When HAoEC cells were exposed to 14dyn/cm2 
for 48 hours in a flow chamber (Ibidi system), the depletion of AmotL2 by a Lentivirus-
based approach resulted in failure to elongate and align with the direction of flow as well as 
the absence of radial actin firmaments crossing cells. 
Remarkably, we were able to induce an artery-like phenotype in venous HUVECs simply 
by re-expressing AmotL2. The localization of AmotL2 could be observed at cell–cell 
junctions in Lenti-AmotL2 transfected cells, which overlapped with VE-cadherin by both 
immunostaining and PLA. Interestingly, AmotL2 over-expression was sufficient to induce 
radial actin filament formation and to elongate and align cells even under static conditions. 
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VE-cadherin has been proposed to associate PECAM-1/VEGFR2 as a mechanosensory 
complex facilitating ECs in response to flow shear (Conway et al., 2013b). Consistently, 
our data demonstrated that a VE-cadherin/AmotL2 junctional complex modulates 
mechanical tension across ECs, which is required for cell alignment in arterial ECs. 
4.4.2 Inactivation of AmotL2 alters aortic nuclear shape and positioning. 
The nucleus is the largest organelle of the cell, and its shape and positioning are determined 
by mechanical challenges from actin filaments to the nuclear lamina (Lele, Dickinson and 
Gundersen, 2018). As ECs are exposed to the hemodynamic drag by the blood flow, EC 
nuclei elongate and nuclei orient themselves relatively in the middle of the cell in response 
to flow. In amotl2ec+/ec+ mice, endothelial nuclei of the DA were orientated in parallel with 
cell alignment in the direction of blood flow. However, in amotl2ec-/ec- ECs, the nuclei were 
rounded with irregular shapes and positioned close to the cell edge downstream of the 
direction of flow. These changes in nuclear shape and positioning were not observed in the 
IVC. Consistent results were obtained from in vitro experiments, in which nuclei from 
AmotL2-depleted HAoECs failed to be elongated and positioned near the center of cells 
under flow condition. These data indicated that the VE-cadherin/AmotL2/actin complex is 
required for proper nuclear positioning and alignment. 
4.4.3 AmotL2 couples VE-cadherin to nuclear membrane through radial 
actin filaments.  
Actin filaments are coupled to the nuclear membrane through the LINC complex, which 
consists of SUN/Nesprin proteins connecting to Lamin A/C of the nuclear lamina. The LINC 
proteins have also been demonstrated to relay mechanical signals between the cytoskeleton 
and the nucleus and thereby control nuclear positioning (Zhu, Antoku and Gundersen, 2017; 
Chang et al., 2015; Gundersen and Worman, 2013a; Lee and Burke, 2018). Next, we 
investigated a possible connection between VE-cadherin, AmotL2, Actin, and the LINC 
complex. As we speculated, Lamin A/C, together with a few other molecules located in 
nuclear membranes, was identified from AmotL2 Co-IP in two endothelium cell lines (BAE 
and MS-1) through MS analysis. Notably, we verified this association in vivo IP from mouse 
lungs (which contain 30% ECs), which supported that AmotL2 binds with VE-cadherin, 
actin, and Lamin A/C. Furthermore, this association was proven to be dependent on myosin 
contraction and actin filaments, as both treatments with blebbistatin (the myosin II inhibitor) 
and cytochalasin D (the actin polymerization inhibitor) were able to inhibit the connection 
between AmotL2 and Lamin A/C. Additionally, IP of VE-cadherin confirmed that the 
association of VE-cadherin and Lamin A/C relies on AmotL2 as a link. Taken together, we 
proposed a novel mechanical pathway through which VE-cadherin/AmotL2 forms a complex 
that is connected to the nuclear LINC complex via actin filaments. 
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4.4.4 Deficiency of AmotL2 provokes vascular inflammation and aortic 
aneurysm. 
The findings of such critical changes in amotl2ec-/ec- EC properties raised the question of 
whether impaired mechanotransduction of the EC could result in vascular inflammation or 
other severe consequences in such a high shear stress exerted from the blood flow. Due to the 
distinct properties of shear stress caused by the blood flow in the aortic arch (turbulent flow) 
and the DA (laminar flow), we separated the aortic arch and the DA into two distinct aortic 
tissues for further studies.  
Whole mount immunostaining with CD45 (a general marker for leukocytes) antibodies in 
aortic arches in 45% of the amotl2ec-/ec- animals. The macrophage-like CD45+ cells resided 
physiologically in the inner curvature of the arches, however, the cells attached in the 
amotl2ec-/ec- arches were monocyte-like round cells, and some of them invaded the smooth 
muscle layers in intima. Due to the size difference between mice and humans, a mouse model 
has limitations in mimicking human situations; for example, atherosclerosis in humans 
usually occurs in carotids and coronary arterials, whereas in mice, the pathological change 
can be observed in the aortic arch (Getz and Reardon, 2012). Therefore, it is consistent with 
the clinical findings that initiation of atherosclerosis is characterized by monocytes 
infiltrating the arterial wall and thereafter differentiates to macrophages (Tsujikawa et al., 
2019).  
Aortic inflammation commonly leads to aneurysm formation as inflammatory aortic 
aneurysms account for 5% to 10% of all AAA cases. Indeed, during aorta dissection under 
the stereomicroscope, we found that observable AAAs formed in 5 out of 45 amotl2ec-/ec- mice 
(25 males and 20 females), all of which were males (20% incidence), whereas no aneurysms 
were found in any of the 36 amotl2ec+/ec+ mice (20 males and 16 females). The detected 
aneurysms occurred in the proximal of the renal artery branch of the DA. It is noteworthy that 
the actual AAA incidence in amotl2ec-/ec- mice might be largely underestimated due to their 
limited size in early developmental stages. Through IHC staining on cross-sections, media 
degradation and fibro-muscular hyperplasia were observed at the amotl2ec-/ec- aneurysm, and 
these pathological changes caused subsequent detrimental changes such as endothelial 
rupture and inflammatory invasion into peripheral renal arteries. The direct impacts of these 
changes on elastin were profound, as the elastic layer was disrupted and degraded at the sites 
where inflammatory cells invaded. 
The mRNA expression level of immune-related genes by RT-qPCR revealed a significant 
increase of general inflammatory markers of Il6, Tnf, and Cd68 (macrophage marker) in both 
aortic arches and DAs, suggesting an activation of general and global immune response in 
amotl2ec-/ec- mice. To clarify which types of immunoresponse were induced, we examined 
chemokines such as Ccl2/MCP1 (monocyte chemoattractant protein 1), Ccl5, and Cxcl10 
(NK cells), which are frequently up-regulated in experimental models of inflammatory 
diseases and thereby considered a hallmark for inflammatory cell infiltration (Aukrust et al., 
2008). Significant up-regulation of Ccl2 and a slight increase in Ccl5 and Cxcl10, which were 
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markers for monocyte, neutrophils, and NK cells penetration respectively, suggested a 
specific infiltration of monocytes in aorta, especially in DAs. By contrast, the T and B cell 
markers Cd4, Cd8, and Cd19 did not exhibit a significant difference on the mRNA level in 
amotl2ec-/ec- aortae. These data supported the conclusion that it was the innate rather than 
adaptive immune response that was provoked by AmotL2 deletion.  
In summary, we propose that AmotL2 is essential for EC alignment and nuclear positioning 
in response to arterial shear stress. Inactivation of this pathway induces a pro-inflammatory 
immune response ultimately leading to the degradation of the aortic wall and resulting in the 
formation of an aortic aneurysm (Figure 15). 
 
Figure 15. Hypothetical schematic of the formation of an AAA. The step-by-step formation of an AAA includes 
EC activation, immune cell rolling and attachment, leukocyte extravasation, macrophage differentiation, 
thrombus formation, and finally, lumen dilation (aneurysm). Illustrated by Yu-Hsuan.  
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5 CONCLUSIONS 
Using a combination of experimental animal studies, molecular analysis, and biophysical 
technologies, my thesis highlights three mechanosensory pathways mediated by the Amot 
proteins. I provide evidence that the Amot protein family manipulates biomechanical 
complexes to orchestrate intrinsic and extrinsic forces driving vascular development.  
More specifically, 
• The Amot/Integrin protein complex at focal adhesion transmits mechanical forces 
required for both physiological and pathological vascular sprouting. 
• The AmotL1/N-cadherin complex affects endothelial/pericyte attachment in normal 
and tumor angiogenesis. 
• The AmotL2/VE-cadherin complex at endothelial cell-cell junction suppresses aortic 
inflammation and the formation of abdominal aortic aneurysms 
Additionally, an integrin binding switch mediated by the Fn force-sensing domain has been 
newly identified. Moreover, a mechanosensitive scFv probe named H5 has been engineered 
to recognize and target the strained Fn that is subjected to enhanced forces in tissues. 
 
Figure 16. Ready to pull-force transmission during vascular development. A schematic summarizes 
the findings in this thesis. Paper I: During vascular development, endothelial tip cells migrate by 
interacting with ECM through the Amot/integrin focal adhesive complex. Paper II: A separate image 
at the bottom left delineates α5β1 integrin switch between the FnIII9*10 (unextended) domain to the 
FnIII-4G-10 (extended) domain of Fn, as well as the specific binding of H5-scFv to extended Fn. 
Paper III: EC and pericyte form AmotL1/N-cadherin adhesive junction complexes. Paper IV: ECs 
connects to each other through an AmotL2/VE-cadherin junctional protein complex. Illustrated by Yu-
Hsuan Hsu.  
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6 FUTURE PERSPECTIVES 
The field of mechanobiology is rapidly expanding and its implications for our understanding 
of human disease are becoming increasingly clear. The holistic view of mechanical forces 
and transduction pathways should be integrated into our mind, when we perceive molecular 
knowledge.  
During the writing of this thesis I have begun to contemplate the future directions for 
translating existing data into clinical approaches and how to address the questions those 
findings have raised. 
6.1 Mechanobiology development 
The optimization of the engineering technologies concerning more feasible force indicators 
will be subject to further studies to develop new materialistic measurements. If the whole 
aortic endothelium surface could be mapped as a force landscape, we could directly visualize 
the lumen topography under the blood flow: points/area with altered force due to disturbed 
flow, where ECs are under high tension with a higher risk to be deformed et cetera. This 
would be extremely helpful in managing diseases with more precise intervention and 
treatment. Conwey and colleagues have developed FRET-based tension sensors for VE-
cadherin and PECAM-1, and these enable the visualization of increased junctional tension in 
real time when the fluid shear stress is switched on (Conway et al., 2013a). AmotL2/VE-
cadherin, in my view, might also be a good pair of sensors due to AmotL2’s preferential 
expression in arteries, where higher shear stress is applied.  
With the probe H5 that we generated, combined with pan-Fn, we can delineate a force map in 
mouse fibrotic lung tissue and developing retinal vessels, and this might shed light on the 
early diagnosis or target-treatment of fibrotic tissues. Similar probes targeting specific Fn 
conformation change have been reported, including phage-based molecular probes LNLPHG 
and RFSAFY (Cao et al., 2012) and peptide probes FnBPA5 (Arnoldini et al., 2017); 
however, further work need to be done to evaluate the specificity and limitation. 
There are a number of challenges in this field including but not limited to the following:  
1) Most approaches that have been developed remain at the in vitro and ex vivo levels, and it 
remains necessary to generate a harmless but convincing probe that can be used in vivo.  
2) Resolution and sensitivities requires improvement. Force in the range of a few pNs can be 
detected in studies of actomyosin contractile force (Finer, Simmons and Spudich, 1994) and 
single strand DNA molecules (Bustamante, Bryant and Smith, 2003). However, the fN 
(femtoNewton) range might be the case referring to subcellular recording.  
3) The techniques of probing the cellular force usually require complicated expertise to 
operate and produce, resulting in difficulties and high cost to be used as laboratory tools.  
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6.2 AmotL2: missing puzzle for vascular conundrum? 
Transforming vein to artery? 
Every year millions of patients with coronary atherosclerosis are operated on worldwide via 
heart and peripheral bypass surgery. Surgeons use the saphenous vein to replace the clogged 
coronary arteries due to easier access to the vein material. However, half of vein graphs fail 
after 10 years due to unexpected atherosclerosis (McKavanagh et al., 2017). The sudden 
exposure to the increased shear stress and wall tension damaging the endothelium and SMC 
is one of the main causes of graft failure (ANGELINI et al., 1987).  
Abrogation of AmotL2 in adult mice is not lethal but affects actin filaments that connect the 
ECs to each other. This results in a cytoskeletal phenotype and shape similar to venous 
endothelium and raises the question of whether introducing AmotL2 into venous endothelium 
could confer stability to venous ECs subjected to higher flow. A well established mouse 
model of venous bypass graft arteriosclerosis with a perivascular “cuff” has been developed 
(Zou et al., 1998), in which a vena cava piece from donor mouse is end-to-end grafted into 
carotid arteries. We may re-engineer the endothelium with AmotL2 by Lentvirus transfection 
before grafting and evaluate whether enhanced F-actin and junctional binding enable venous 
endothelium to sustain arterial flow. 
Rescuing aging blood vessels? 
According to data from various American cohort studies, about 60% of middle-aged men and 
slightly more than 50% of middle-aged women develop cardiovascular disease in their life 
(http://www.ehnheart.org/cvd-statistics.html). Apparently, aging is a significant risk factor for 
cardiovascular diseases. We noticed from our study that AmotL2 is expressed in arteries of 
mouse retina, but barely detected in 15-month-old mice. We therefore hypothesize that the 
ability of EC to sustain shear stress might be age-dependent. To investigate this, we analyzed 
AmotL2 expression level during mice aging (1-20 months) and found a negative correlation 
between AmotL2 and age in mouse lung (ECs account for 30%) and heart tissue (Stanford 
public database http://cmgm.stanford.edu/~kimlab/aging_mouse/).  
Moreover, there is strong experimental and clinical evidence that “inflammaging” is a key 
contributors to aging (Franceschi et al., 2000), and age-related vascular inflammation is a 
major cause of macro- and micro- vascular pathologies (Ungvari et al., 2018). Considering 
that the absence of AmotL2 induce an inflammatory response, we might be able to inhibit 
vascular inflammation by restoring AmotL2 and thus subsequently arrest vascular aging. 
6.3 YAP/AmotL2 signaling in vascular system and cancer 
Previous report has confirmed AmotL2 as a direct transcriptional target of YAP from human 
MCF10A cells, mouse NIH3T3 cells and mouse liver tissue (Dupont et al., 2011). In Paper 
IV, in an endothelial system, we provide strong evidence of a positive correlation (r = 0.80) 
of AmotL2 and YAP expression in the media of human aortae derived from AAA patients. 
This is of interest in evaluating whether a YAP signaling cascade includes AmotL2. 
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YAP has been identified as a major response factor of the mechanical force and implicated in 
vascular diseases due to its dysfunction (He et al., 2018). However, its function cannot 
simply be concluded. The inhibition of YAP suppresses vascular inflammation and retards 
atherogenesis (Wang et al., 2016c); however, YAP up-regulation acts as a protection factor 
for aortic dissection (Liu et al., 2017). In addition to the vascular system, extensive studies 
have suggested that YAP is a tumor promoter in various cancer types, as reviewed by 
(Shibata, Ham and Hoque, 2018). An obvious challenge for the use of YAP as a therapeutic 
target is the question of how to balance the expression of YAP systematically and avoid the 
off-target effect. This motivates us to consider and research its downstream targets in specific 
physiological and pathological processes. After all, patients do not want to suffer from a new 
disease by the treatment.  
 
To close my thesis: 
Beyond the known unknown, there is always the unknown unknown to discover.  
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